Skip to main content
Wellcome Open Research logoLink to Wellcome Open Research
. 2025 Mar 7;9:234. Originally published 2024 May 2. [Version 4] doi: 10.12688/wellcomeopenres.21010.4

Empowering Global AMR Research Community: Interactive GIS dashboards for AMR data analysis and informed decision-making

Stephen Obol Opiyo 1,2,3,a, Racheal Nalunkuma 4, Stella Maris Nanyonga 5, Nathan Mugenyi 6, Andrew Marvin Kanyike 4
PMCID: PMC11910713  PMID: 40093312

Version Changes

Revised. Amendments from Version 3

In response to the reviewers' comments, we have made substantial revisions to improve clarity, structure, and accuracy. These changes enhance the manuscript's organization and ensure our findings are clearly presented. First, we revised the abstract, removing the phrase "simplifying data interpretation for diverse users and supporting informed decision-making processes" to avoid implying that decision-making processes were analyzed. The abstract now accurately reflects the study's focus on AMR data accessibility, and visualization, especially in Sub-Saharan Africa. We restructured the Results and Discussion sections to improve readability. The Results section now systematically presents AMR data distribution, while the Discussion contextualizes these findings in relation to existing problems dealing with AMR data in Sub-Saharan Africa. To address concerns about alternative tools, we clarified why Excel and Tableau are insufficient for AMR analysis in Sub-Saharan Africa. Excel struggles with large datasets, lacks geospatial features, and requires technical expertise. Tableau is costly and often inaccessible to low-resource institutions. In contrast, our custom-built, open-source dashboard integrates African-specific AMR data, provides an intuitive interface, and operates efficiently on low-spec computers. Our dashboard eliminates the need for tedious filtering, offering real-time visualization and integrated data access tailored for African researchers. Additionally, we explicitly stated that our GIS-based tool is for visualization, not spatial analysis. We also incorporated a formal endorsement from Mr. Sylvester Z. Moyo, validating the dashboard's practical benefits for African AMR researchers. Overall, these revisions improve the manuscript's accuracy and coherence while addressing reviewer concerns. We appreciate the feedback that has strengthened our study's impact.

Abstract

Background

Antimicrobial Resistance (AMR) poses a global public health challenge, necessitating advanced tools to support data analysis, and visualization. This study introduces interactive Geographic Information System (GIS) dashboards as innovative platforms for AMR data analysis and visualization, offering comprehensive insights into resistance patterns, and geographic distribution across multiple countries, with a specific focus on Africa.

Methods

Three GIS dashboards were developed to address key objectives. The first integrates over 860,000 ATLAS data points from 83 countries, providing an interactive platform. Users can filter data by variables such as country, year, and region, enhancing data accessibility and visualization. The second dashboard focuses on the ATLAS dataset for Kenya and Uganda, incorporating detailed variables such as species, sample sources, and resistance phenotypes. The third involves Kampala, Uganda, to fill data gaps, enabling localized analyses through interactive features like geographic mapping and sample breakdowns by year.

Results

Sub-Saharan Africa faces three major challenges in handling antimicrobial resistance (AMR) data: limited accessibility for non-technical users, inefficiencies in processing large datasets, and insufficient longitudinal data for analysis. The introduction of interactive dashboards significantly improved AMR data visualization and interpretation across different scales. The global AMR dashboard effectively mapped geographical trends, uncovering critical data gaps, particularly the scarcity of AMR records from Africa. The Kenya and Uganda dashboard revealed key resistance patterns, highlighting the ineffectiveness of Ceftriaxone, Erythromycin, Levofloxacin, and Ampicillin against E. coli isolates. Additionally, the Kampala-specific dashboard, developed using simulated data, demonstrated the potential for localized AMR visualization, providing valuable insights where real-world data is limited. Across all platforms, the dashboards' interactive features enhanced data accessibility and streamlined trend identification, making AMR insights more interpretable, especially for researchers in Sub-Saharan Africa.

Conclusions

Interactive GIS dashboards enhance AMR data analysis in Sub-Saharan Africa by improving accessibility, efficiently handling large datasets, and addressing data gaps. Unlike spreadsheets such as Excel, which struggle with large datasets due to computer constraints, dashboards offer dynamic visualization, real-time updates, and intuitive data exploration.

Keywords: Antimicrobial Resistance (AMR), Geographic Information System (GIS) dashboards, Data analysis, Informed decision making

Plain Language Summary

Antimicrobial Resistance (AMR) is increasingly serious global health issue, making it harder to treat common infections due to the reduced effectiveness of antibiotics. To address this challenge, researchers, healthcare providers, and professionals need tools to better understand AMR. This study introduces an interactive tool in the form of Geographic Information System (GIS) dashboards, which allow users to explore and analyze AMR datasets. The first objective was to create a global map that tracks antibiotic usage and resistance trends across multiple countries, enabling users to zoom in on specific areas, such as countries or years, for more detailed insights from ATLAS dataset. The second objective was to develop maps for Kenya and Uganda, highlighting the unique AMR challenges faced in these countries. The third goal focused on using this tool to address data gaps in Kampala, Uganda, and help users analyze AMR trends. These interactive maps are highly valuable. The global map reveals trends and identifies areas where data is lacking, especially in Africa. The maps for Kenya and Uganda show concerning resistance levels, where antibiotics are becoming ineffective against bacteria like E. coli. The Kampala map demonstrates how the tool can help provide a more detailed analysis of local AMR issues. Overall, these maps make it easier for experts to explore AMR data and identify key trends. In simple terms, these GIS dashboards are powerful tools for communicating and raising awareness about AMR. They allow us to visualize the spread of resistance and explore detailed AMR data. These interactive dashboards could play a crucial role in the global effort to combat AMR.

Introduction

AMR stands as a formidable global challenge, deeply intertwined with the framework of public health and healthcare systems across the world 1 . Despite AMR's significant burden in sub-Saharan Africa, data on the region's AMR rates remain scarce 2 . There is an urgent need to improve antibiotic stewardship and create context specific treatment guidelines, particularly in East Africa, where high rates of microbiologically confirmed urinary tract infections (UTIs) are driven largely by multidrug-resistant (MDR) Escherichia coli and Staphylococcus spp. 3 . Research spotlighting antibiotic usage in hospitalized neonates reveals elevated mortality rates linked to culture-positive sepsis and notable antibiotic resistance 4 . Diverse antibiotic regimens, often divergent from global guidelines, underscore the need for pragmatic trials to identify effective antibiotic protocols in regions grappling with substantial AMR challenges. Studies examining hurdles in implementing antimicrobial use (AMU) surveillance in Tanzania and Uganda highlight issues such as poor data quality, limited digitalization, and inadequate resources, underscoring the necessity for capacity building and continuous quality improvement 5 . The evolution of national AMR surveillance systems in African countries from 2017 to 2019 is discussed, emphasizing constraints like limited laboratory capacity and staffing 6 . A sustained increase in resistance among commonly used antibiotics in surgical wards of a Ugandan hospital from 2014 to 2018 underscores the need for ongoing monitoring, surveillance, and infection prevention and control practices 7 .

Dashboards are powerful visual tools designed to consolidate and display diverse yet related data in one centralized location, making complex information easier to understand, analyze, and act upon 8 . By integrating data from multiple sources, dashboards utilize visual elements such as graphs, charts, and tables to provide interactive overviews of key metrics and trends. These tools facilitate informed, data-driven decision-making by offering real-time updates and customizable views tailored to the needs of different users. Dashboards are employed across various industries, including healthcare, marketing, retail, agriculture, sales and other disciplines, where they help monitor performance, measure progress, and identify areas for improvement. They come in various types, such as strategic, analytics, KPI, project, and performance dashboards, each serving specific purposes such as tracking daily operations, visualizing high-level data, or analyzing key performance indicators. The benefits of dashboards include enhanced data clarity, centralized information access, real-time monitoring, and improved decision-making. Additionally, their intuitive design fosters better communication and collaboration 8 . However, creating and maintaining dashboards requires technical expertise, consistent updates, and reliable data to ensure accuracy. Challenges such as high costs, information overload, and limited context can reduce their effectiveness if not carefully managed. Despite these challenges, dashboards remain essential tools for simplifying complex datasets and generating actionable insights 8 .

Interactive Geographic Information System (GIS) dashboards integrate spatial data with traditional datasets to provide geographical context for analysis and decision-making in various sectors, including public health, disaster management, urban planning, and agriculture 9 . GIS tasks span a wide range of processes, from data collection through techniques like GPS gathering and sensor integration, to data preprocessing, including image preparation and format standardization 10, 11 . Data is often stored in solutions such as spatial data infrastructures and geodatabases, while spatial data mining techniques are employed to extract insights. Collaborative workflows are supported through multi-user geodatabases, while visualization tools facilitate the clear presentation of data via mapping and geo-visualization 12 . Decision support tools, such as multi-criteria evaluation and suitability analysis, aid in strategic planning, while spatial analysis techniques like autocorrelation and hotspot analysis reveal patterns. Additional GIS functions include modeling, which simulates scenarios, and data dissemination through Web GIS, interactive maps, and geoportals, ensuring that spatial information is accessible and actionable 9, 11, 12 .

Numerous studies underscore the critical role of dashboards in advancing AMR monitoring and stewardship. For example, the design of an AMR surveillance system tailored for neonatal intensive care units (NICUs) in Iran addresses inefficiencies in data analysis and reporting within antimicrobial stewardship programs. This system leverages principles of user experience design and business intelligence to ensure practical applicability 13 . Similarly, integrating antibiotic stewardship indicators from electronic medical records (EMRs) highlights the potential of algorithmic data conversion and interactive dashboards to assess the appropriateness of antibiotic use, despite challenges like insufficient data quality and metadata categorization. These advancements emphasize the necessity of structured, interdisciplinary approaches to AMR surveillance to close critical data gaps 14 . Kenya’s One Health AMR Surveillance System (OHAMRS) integrates human and animal health data to visualize AMR patterns across sectors 15 , while Switzerland’s Swiss Pathogen Surveillance Platform (SPSP) leverages genomics and metadata for outbreak monitoring and data sharing 16 . Globally, Merck’s SMART Surveillance program provides a robust dashboard tracking AMR trends across 83 countries, offering region-specific resistance insights 17 . These initiatives underscore the significance of scalable and interoperable dashboards in enabling data-driven policies and fostering global collaboration. In Nepal 18 , dashboard could be useful for streamlining AMR data management by providing real-time, dynamic visualization and analysis of standardized data, enabling evidence-based decision-making and efficient reporting for initiatives like WHO-GLASS 19 . In Canada, The OHE-AMURS tool excelled by providing a structured, adaptable framework to evaluate AMR/AMU surveillance systems, synthesizing diverse knowledge sources, and using a transparent, repeatable matrix to assess 36 components across seven sustainability elements 20, 21 . Its flexibility and robustness supported comprehensive evaluations of complex systems. However, further refinement is needed to better assess the scope of surveillance components and address coverage gaps.

Despite their transformative potential, AMR dashboards face significant challenges that can hinder their effectiveness. Insufficient data quality and gaps in metadata categorization remain persistent issues, limiting the accuracy and comprehensiveness of insights derived from these tools. For example, while integrating antibiotic stewardship indicators from EMRs can provide valuable data, the reliance on incomplete or poorly categorized metadata can undermine the reliability of algorithmic analyses. Additionally, the implementation of such systems often demands structured, interdisciplinary collaboration, which can be difficult to achieve due to varying expertise, resource availability, and sector-specific priorities. Scalability and interoperability, crucial for global initiatives like Kenya’s OHAMRS or Merck’s SMART Surveillance program, can also pose technical and logistical hurdles, especially in low-resource settings. Furthermore, the complexity of integrating diverse datasets from human, animal, and environmental health sectors, as seen in tools like the AR Dashboard, can lead to fragmented data visualization and hinder real-time decision-making. These limitations underscore the need for improved data infrastructure, enhanced training, and coordinated multi-sectoral efforts to maximize the potential of AMR dashboards.

The 2023 Vivli AMR Surveillance Data Challenge sought to advance antimicrobial resistance (AMR) research by encouraging the use of the Vivli AMR Register 22 . This initiative enabled researchers to analyze surveillance data shared by GSK, Johnson and Johnson, Merck, Pfizer, Shionogi, Paratek, and Venatorx (with Merck's data excluded for the challenge). The goal was to detect resistance trends, inform policies, and model future scenarios. As part of this effort, we expressed interest in working with AMR data and submitted an abstract 23 for the Pfizer Antimicrobial Testing Leadership and Surveillance (ATLAS) dataset 24, 25 .

Objectives

Upon receiving the dataset in a comma separated (CSV) format, we observed data gaps in African countries and that this motivated our three objectives. The dataset had limited data from African countries (13 out of 54 countries), making it difficult to generalize findings across the continent. Furthermore, the available data from African countries covered less than five years, reducing its usefulness for comprehensive analysis. Although we discovered a dataset from Uganda, it only contained information for 2021, while the dataset for Kenya spanned 2013, 2014, and 2021. Additionally, many researchers and public health officials in Sub-Saharan Africa face significant challenges in accessing and analyzing AMR data due to fragmented datasets, computational infrastructure limitations, and gaps in technical expertise ( Figure 1). The lack of high-performance computing resources in many institutions makes it difficult to process large datasets efficiently, while incomplete or poorly structured data further complicates analysis. Consequently, we adjusted our research approach to develop tools that address these challenges and beyond this competition. To fulfill this aim, we outlined the following objectives:

Figure 1. Barriers to AMR data analysis and visualization in Sub-Saharan Africa, including fragmented datasets, and limited computational infrastructure.

Figure 1.

Objective 1. Develop an interactive GIS dashboard using the Pfizer ATLAS dataset to complement spreadsheets. The dashboard will enhance AMR data exploration with real-time filtering and interactive visualization, making it more accessible and effective in resource limited settings.

Objective 2. Create an interactive GIS dashboard specific to the Pfizer ATLAS data from Kenya and Uganda. This focused dashboard would provide a more detailed view of the data from these two countries.

Objective 3. To demonstrate the potential usefulness and design of a dashboard that facilitates the analysis of antimicrobial resistance (AMR) patterns in Kampala, Uganda.

By accomplishing these objectives, we aimed to develop dashboards that would serve as valuable tools for researchers, and healthcare professionals using similar datasets. Ultimately, our goal is to provide a tool that could be utilized beyond the scope of this competition.

Methods

Pfizer ATLAS dataset

The ATLAS program, initiated by Pfizer in 2004, monitors global trends in antibiotic susceptibility, bacterial resistance, and the emergence of new resistance mechanisms across 83 countries 24 . Local laboratories actively collect isolates, which are then sent to a central laboratory for standardized identification and susceptibility testing. This centralized approach ensures consistency in data quality. The program also incorporates genotypic data for selected beta-lactamase genes and antifungal susceptibility data through the SENTRY platform. Using Clinical and Laboratory Standards Institutes (CLSI) breakpoints with optional The European Committee on Antimicrobial Susceptibility Testing (EUCAST) analyses, ATLAS has tested over 850,000 antibiotic isolates and 21,000 antifungal isolates. Each record in the ATLAS dataset represents an individual patient and includes metadata such as the year and country of infection, the pathogen strain, and its classification as resistant, susceptible, or intermediate against a panel of antibiotics. The dataset also provides Minimum Inhibitory Concentrations (MICs) used for these classifications. Supplementary Figure 1 presents a screenshot displaying the initial rows and columns of the ATLAS dataset used in this study, which is available for download on GitHub at 26. The dataset contains 861,351 rows of isolates and 134 columns of variables shown in Supplementary Table 1, which can be downloaded from the GitHub at 27. The ATLAS dataset, derived from diverse surveillance programs, reflects considerable heterogeneity in its structure and content. Antibiotics tested for specific pathogens vary among patients, influenced by the unique requirements of surveillance programs or clinical contexts. Additionally, each MIC value is reported without replication or measures of variation, adhering to standard clinical practices. These factors contribute to significant spatial and temporal heterogeneities in antibiotic resistance patterns across various drug-bacterium pairs, as highlighted in the studies by 28, 29. Leveraging this dataset, which includes classifications of resistant, susceptible, and intermediate isolates, we developed Interactive GIS dashboards.

Dataset for Objective 1. The dataset created for Objective 1 displays the distribution of isolates across 83 countries using a dashboard. It includes the following attributes: Isolate Id, Country, Year of data collection (sourced from the ATLAS dataset), and the geographical coordinates (longitude and latitude) along with the respective country regions, added to ATLAS dataset. The screenshot of the first few rows is visualized in Supplementary Figure 2, which can be downloaded from GitHub 26 . The complete dataset is provided in Supplementary Table 2, also available for download on GitHub 30 .

Dataset for Objective 2. Objective 2 utilizes dataset from the ATLAS dataset, incorporating all 134 variables for Kenya and Uganda, along with the geographic coordinates (longitude and latitude) of Nairobi and Kampala, respectively. Detailed information on dataset is provided in Supplementary Table 3. The dataset can be accessed and downloaded via GitHub at 31.

Dataset for Objective 3. For Objective 3, a dataset was simulated to demonstrate the functionality of the dashboard in Kampala, Uganda. This dataset is outlined in Supplementary Table 4 and is available for download on GitHub at 32.

Statistical analysis

The ATLAS dataset underwent statistics analysis using the R statistical software version 4.2.2 33 .

Chi-square test of proportions

A chi-square test of proportions was performed to examine the distribution of isolates across different regions, including Africa, Asia, Europe, Latin America and the Caribbean, Middle East, and North America. Additionally, another chi-square test was performed to assess the distribution of years of available number dataset across these regions.

Identification of coordinates

To develop an interactive GIS dashboard, it is essential to have latitude and longitude positions for each country. To accomplish this, a coordinate was assigned to the capital city of each country, utilizing information from Wikipedia 34 . These coordinates were then incorporated into the dataset, enabling accurate geographical representation and visualization within the dashboards.

Results

Statistical analysis. The dataset analyzed in this study consists of 83 countries and a total of 861,351 isolates. It encompasses 134 variables and includes information on 345 species. Table 1 provides an overview of the distribution of isolates across different regions and the availability of data over the years. The African region has the lowest number of datasets and the fewest years of available data, while Europe has the highest numbers. Chi-square tests confirmed that both the proportion of isolates in the region and the proportion of countries with at least 9 years of data significantly deviate from the expected proportion of 0.17 (p < 0.001, Table 2 and Table 3).

Table 1. Descriptive statistic results of the Atlas dataset as of June 15 th, 2023: The dataset contains a total of 861,351 isolates.

To determine the proportion, the number of isolates in each region is divided by the total number of isolates. Europe has the most extensive collection of datasets and the longest historical data, contrasting sharply with Africa, which possesses the least abundant dataset count and the shortest temporal coverage.

Africa Asia Latin America
and Caribbean
Middle
East
Europe North
America
Number of isolates 22,908 117,213 96,566 32,129 420,714 171,821
Proportion of isolates
per region
0.03 0.14 0.11 0.04 0.49 0.20

Table 2. The Atlas dataset, as of June 15th, 2023, shows the distribution of countries with 18 years of available data from 2004 to 2021.

We set a criterion where each country should have at least 9 years of data out of the total 18-year period. The proportion was calculated by dividing the number of countries with at least 9 years of data by the total number of countries in each region. Isolates are unevenly distributed across various regions, such as Africa, Asia, Europe, Latin America, and the Caribbean, with Africa having only 13 representatives.

Africa Asia Latin America
and Caribbean
Middle East Europe North
America
Number of countries 13 14 15 8 31 2
Number of countries with at least 9
years of dataset
2 11 8 4 23 2
Proportion of countries with at least
9 years of dataset
0.15 0.79 0.53 0.50 0.74 1.00

Table 3. Chi-square tests of proportions for the distribution of isolates across regions, and of distribution of countries with at least 9 years of dataset.

The availability of dataset years varies among different regions, encompassing Africa, Asia, Europe, Latin America, and the Caribbean, with Africa exhibiting the shortest duration of available data.

Chi-square Df p-value
Proportion of isolates per region 85.713 5 < 0.001
Proportion of countries with at
least 9 years of dataset
69.717 5 < 0.001

Development of web-based interactive GIS dashboards

The dashboards were developed using ArcGIS from Esri 35 and Shiny App 36 .

Objective 1. Develop an interactive GIS dashboard using the Pfizer ATLAS dataset to complement spreadsheets. The dashboard will enhance AMR data exploration with real-time filtering and interactive visualization, making it more accessible and effective in resource limited settings. Displaying the dataset comprising over 860,000 rows from Supplementary Table 2, through an interactive GIS dashboard provides significant advantages over manual spreadsheet analysis, especially in resource limited setting such as Sub-Saharan Africa. In Sub-Saharan Africa, many institutions operate on low-specification computers that struggle with large datasets. Excel’s performance degrades significantly when handling AMR datasets with hundreds of thousands of rows. A dashboard offers immediate visual insights by organizing the data into a user-friendly format. For example, geographic mapping enables users to quickly identify patterns and trends across the 83 countries represented in the dataset. This spatial representation highlights areas with significant data gaps or regions requiring additional data collection, such as Africa, as shown in Figure 2A. Additionally, dashboards allow users to dynamically filter and segment data by country, year, For instance, a user can select a specific country, such as Uganda, to view detailed information like the 76 samples collected there in 2021 ( Figure 2B). This interactivity enables users to focus on the most relevant subsets of data, reducing manual effort and enhancing analysis efficiency.

Figure 2.

Figure 2.

Interactive GIS Dashboards: A) Global Overview for 83 Countries, B) Uganda-Specific View, and C) Africa Regional Trends from 2004 to 2024. The global dashboard (Figure 2 A) features tools such as an interactive map, country selection, regional breakdowns, and intuitive navigation instructions, enabling users to analyze and explore data across multiple countries. In contrast, the Uganda-specific view (Figure 2 B) highlights data collected exclusively for 2021, with a total of 76 isolates, presented through a user-friendly interface designed for simplified data interpretation. Meanwhile, the Africa regional dashboard (Figure 2 C) illustrates the trend of data collection from 2004 to 2024, offering insights into regional patterns and temporal progress.

Furthermore, visualizing sample numbers over time through bar charts or similar graphical formats highlights temporal trends in a way that raw spreadsheet data cannot. Patterns such as increases or decreases in sample collection become immediately evident, as illustrated in Figure 2C, which depicts data collected from Africa between 2004 and 2021. Lastly, integrating these elements into a cohesive, visually compelling dashboard interface makes it a powerful communication tool. Even users unfamiliar with complex datasets can intuitively interpret the information. The dashboard represented in Figure 2 can be accessed via a provided link 37 .

Objective 2. Create an interactive GIS dashboard specific to the ATLAS dataset from Kenya and Uganda. The specialized dashboard aims to provide a comprehensive and detailed perspective on ATLAS data from two specific nations of Kenya, and Uganda (Supplementary Table 3). The dataset comprises comprehensive details across several dimensions for AMR analysis. Each isolate is uniquely identified by an Isolate Id and linked to its source study (e.g., SPIDAAR). Biological and taxonomical data include the bacterial species (e.g., Escherichia coli, Pseudomonas aeruginosa) and their respective families. Geographical and demographic data provide location information (Country) and host demographics (Gender, Age Group). Clinical and contextual data capture details about the clinical specialty involved (e.g., Medicine General), the biological source of the sample (e.g., Urine, Wound), and whether the patient was classified as Inpatient or Outpatient. Temporal data document the year of sample collection. Resistance data consist of resistance phenotype classifications, MICs and Resistant, Susceptible, Intermediate, alongside specific resistance statuses for various antibiotics (e.g., Amikacin_I). Finally, the dataset includes genetic resistance markers such as CTXM1, KPC, and NDM, which indicate underlying resistance mechanisms. We added longitude and latitude for the capital city of both countries in the dataset.

However, this data structure has several disadvantages. Redundancy is a significant issue, as having separate columns for raw antibiotic measurements (e.g., MIC values) and interpretations can make the dataset unnecessarily large. Sparse data is also problematic, as many fields are incomplete, leading to substantial missing values. Furthermore, a lack of standardization in some categorical columns, such as specialty and source, increases variability and complicates analysis. The dataset's flat structure fails to capture complex relationships, such as those between isolates and resistance phenotypes, while geographic data lacks sufficient granularity for nuanced spatial analysis. The high dimensionality, with numerous columns for antibiotics, can lead to computational challenges. Additionally, overloaded columns like Amikacin, which mix qualitative data with quantitative MIC values, create difficulties in analysis, and ambiguous column labels or units hinder interpretation (Supplementary Table 3). Using an interactive GIS dashboard offers several advantages in addressing the challenges presented by the dataset. First, the dashboard enhances data visualization by transforming complex tabular data into intuitive and easily interpretable geographic maps, charts, and graphs. This makes it easier to identify spatial patterns, such antimicrobial resistance, and observe trends across locations and time. By integrating demographic, geographical, and resistance data on an interactive platform, the dashboard provides a unified view that reduces the redundancy and fragmentation inherent in the tabular format.

We developed an interactive GIS dashboard using the ATLAS dataset from Uganda and Kenya to demonstrate the advantages of streamlined data exploration and visualization. This dashboard focuses on key variables highlighted in red in Supplementary Table 3, including species, country, sample sources, sample counts, gender, and antibiotics ( Figure 3A). By providing an intuitive interface, the dashboard eliminates the need to manually search Supplementary Table 3 spreadsheet for specific data related to Uganda and Kenya ( Figure 3B). Users can apply filters based on these variables for targeted analysis, making the exploration of complex datasets efficient and user-friendly. To illustrate antibiotic resistance patterns in Uganda, we focused on E. coli isolate (highlighted in yellow in Supplementary Table 3) and six antibiotics in the columns: Ampicillin_I, Ceftriaxone_I, Erythromycin_I, Imipenem_I, Levofloxacin_I, and Moxifloxacin_I (highlighted in red). Analysis revealed that Ampicillin, Levofloxacin, and Ciprofloxacin were ineffective in 21 samples classified as Resistant, while Imipenem was effective across all samples, classified as Susceptible ( Figure 3C). Among the resistant samples, 12 originated from wounds, four from urine, and five from other sources ( Figure 3C).

Figure 3.

Figure 3.

Interactive GIS Dashboards: The figure illustrates three components: A) a combined dashboard for Kenya and Uganda, highlighting key data points such as species, country, sample sources, counts, gender, and antibiotics; B) separate dashboards for Kenya and Uganda, offering country-specific insights; and C) antibiotic resistance in E. coli samples from Uganda, revealing resistance to Ampicillin, Levofloxacin, and Ciprofloxacin (red circles) in 21 samples, while all samples remained susceptible to Imipenem (green circle).

This dashboard simplifies the visualization of antibiotic response data, offering a significant improvement over manually reviewing rows in Supplementary Table 3 for E. coli and comparing antibiotic resistance patterns. A similar interactive GIS dashboard can be adapted for use in countries where antibiotic test results are still recorded on paper, as highlighted in a recent study by The Mapping Antimicrobial Resistance and Antimicrobial Use Partnership (MAAP) 38 . MAAP analyzed 819,584 AMR records collected between 2016 and 2019 from 205 laboratories across 14 countries: Burkina Faso, Cameroon, Eswatini, Gabon, Ghana, Kenya, Malawi, Nigeria, Senegal, Sierra Leone, Tanzania, Uganda, Zambia, and Zimbabwe. The study also included data from 327 hospital and community pharmacies and 16 national-level antimicrobial consumption (AMC) datasets, with some laboratory datasets being paper-based. By integrating such datasets into a digital, interactive GIS dashboard, these countries could significantly enhance their capacity to visualize and interpret AMR data. This tool would not only improve data accessibility but also empower laboratory technicians and researchers working with similar datasets.

The interactive GIS dashboard offers enhanced data exploration capabilities. Users can dynamically filter data based on criteria such as location, species, age group, or antibiotic type, enabling customized analyses without modifying the original dataset. This interactivity supports real-time comparisons and layered visualizations, uncovering relationships and correlations that may not be immediately evident in a spreadsheet format, such as that shown in Supplementary Table 3. Additionally, the dashboard provides a clear way to handle missing data by labeling it distinctly. For instance, missing values can be visualized as "No Information," as illustrated in Figures 3B and 3C for antibiotics, highlighting data gaps and guiding efforts to prioritize data collection. The dashboard can be accessed via a provided link 39 .

Objective 3. Demonstrate the functionality of the dashboard in Kampala, Uganda. As demonstrated in Supplementary Tables 2 and 3, as well as Figure 2B, Figure 3B and Figure 3C, Uganda had data available only for 2021. This suggests a potential lack of datasets specifically for Kampala, Uganda. To address this gap, we simulated a dataset modeled after ATLAS. Our simulated data focuses on analyzing various regions within Kampala, as illustrated in Figure 4. The dashboard [1], illustrated in, provides a comprehensive and interactive visualization of antibiotic resistance data using the R Shiny dashboard framework. At the top, a welcome message instructs: “Welcome to the Antibiotic Resistance Dashboard. Please select a species from the dropdown menu on the left to view relevant data visualizations. Click on 'Download Results' to access the Species ID and download the data in CSV format.” At the top left [2], users can choose from various species via a dropdown menu, with " Staphylococcus aureus" selected by default. Below this selection is the "Download Results" button [3], allowing users to export data in CSV format. The Source Distribution plot [4] showcases the count of samples across different sources such as "Abscess”, “Blood”,” Burn”, and others.

Figure 4.

Figure 4.

Interactive GIS dashboards: A) simulated Kampala data, B) Klebsiella aerogenes from only Lugala. Figure 4 A displays the simulated data examining various regions within Kampala, while Figure 4 B highlights the 2019 and 2021 detection of Klebsiella aerogenes exclusively in Lugala, revealing three resistance to Ampicillin but susceptibility to Amikacin. This simulated dataset, offers crucial insights into AMR trends and can be used to empower stakeholders for more informed decision-making.

To the right of the source plot, a Geographical Distribution map [5] displays regional markers across Kampala, with interactive hover functionality revealing the name of each region and clickable markers that provide the total sample count for that region. Additional visualizations include the Samples by Year bar plot [6], which depicts the number of samples collected during the years 2019, 2020, 2021, and 2022. A Gender Distribution pie chart [7] illustrates the percentage of male and female participants, with a click feature revealing both the count and percentage values. Lastly, the Antibiotic Resistance plots [8] visualize resistance levels for antibiotics such as Amikacin (green) and Ampicillin (red), categorized into Intermediate, Resistant, Susceptible, or lacking information 40 .

For illustration purpose, when " Klebsiella aerogenes" is selected from the species dropdown ( Figure 3B), the dashboard dynamically updates to display K. aerogenes visualizations. The Source Distribution Chart indicates that samples were collected from “Respiratory: Other” (3 samples) and “Urine” (1 sample). The Geographical Distribution Map pinpoints Lugala as the sole location of K. aerogenes cases, with a total of four cases reported. Additional insights are provided by the Samples by Year Plot, which shows an increase in sample counts over time: 1 sample in 2019, 1 sample in 2020, and 2 samples in 2021. The Antibiotic Resistance Charts reveal full resistance to Ampicillin (red, 4 cases) but full susceptibility to Amikacin (green, 4 cases). Users can export the filtered data using the "Download Results" button, which generates a CSV file. Notably, in 2021, K. aerogenes demonstrated resistance to Ampicillin (2 cases) while remaining susceptible to Amikacin (2 cases). Access the R Shiny dashboard via the provided link 40 . It should be noted that this dashboard is solely for data visualization and presentation and does not perform any spatial analysis.

Discussion

The GIS-based platform vs. MS Excel and Tableau

In Sub-Saharan Africa, many institutions operate on low-specification computers that struggle with large datasets, gap in training, and lack of resources and limit the use of commonly used data analysis tools such as Microsoft Excel 41 and Tableau 42 . While these tools offer basic data filtering and visualization functionalities, they are not fully equipped to handle the complexities of AMR data analysis in resource-constrained settings. Microsoft Excel, for instance, has severe computing constraints when dealing with large datasets, which is a critical issue in AMR surveillance where datasets often contain hundreds of thousands of records. Many public health institutions in Africa operate on low-specification computers, and Excel’s performance degrades significantly when processing such extensive data. Additionally, there is a skills gap among AMR researchers in Africa, as many lack advanced Excel training and rely primarily on basic functionalities. This reliance leads to inefficiencies in data extraction and analysis due to the need for repeated manual filtering and multi-step workflows. More importantly, Excel lacks geospatial analytics, limiting its ability to analyze AMR patterns based on geographical distribution, a crucial factor in understanding resistance trends across different regions.

Similarly, Tableau presents financial and accessibility barriers for AMR surveillance in Sub-Saharan Africa. Tableau is a commercial software that comes with high licensing costs, making it unaffordable for many institutions in low-income countries where AMR surveillance is urgently needed Tableau. Even though Tableau provides robust visualization tools, it does not inherently support the integration of multiple AMR surveillance sources, nor does it accommodate the inconsistent reporting structures often found in African datasets. Furthermore, effective use of Tableau requires specialized training, which poses an additional hurdle for public health professionals who may not have the resources or time to undergo such training Tableau. Given these limitations, our GIS-based platform offers a much-needed solution specifically designed to address the unique challenges of AMR data analysis in Sub-Saharan Africa. Unlike existing tools, our platform is built to bridge data gaps by integrating AMR data from multiple African sources, counteracting the underrepresentation of African AMR trends in global surveillance networks such as ATLAS, which currently includes data from only 13 out of 54 African countries, with limited years of data per country (ATLAS, 2023). Additionally, our dashboard is designed for usability, ensuring that non-technical users can access and interpret AMR data without requiring advanced data processing skills.

Challenges in developing the interactive GIS dashboards

Esri ArcGIS dashboards. The authors encountered multiple challenges while designing dashboards using ArcGIS dashboards, necessitating innovative solutions and adaptive strategies. One major hurdle was the platform's complexity and steep learning curve, which required users to possess a strong understanding of GIS concepts and Esri's tools. To address this, the team took a proactive approach to self-learning. They relied heavily on freely available online resources such as YouTube tutorials, which provided practical, step-by-step guidance on building and optimizing dashboards. This hands-on approach was complemented by extensive reading of official documentation, articles, and related materials, enabling the team to deepen their knowledge and effectively navigate the platform’s advanced features.

The challenges of handling large datasets were particularly pronounced, especially with the 645 MB ATLAS dataset with more than 860,000 rows and 134 columns. To optimize the dashboard's performance, the authors implemented several key strategies. For Objective 1, they reduced the dataset by selecting only three essential variables (Isolate Id, Country, and Year) out of the original 134 detailed in Supplementary Table 1. To enhance spatial analysis, they also incorporated geographic data such as regions and latitude and longitude. For Objective 2, they narrowed their focus to data from Uganda and Kenya, which not only reduced the dataset size but also allowed for a more targeted and manageable analysis. Additionally, the issue of missing data was addressed by labeling such entries as "No Information.", Figures 3A and 3B. This approach ensured completeness while improving interpretability for users, making the dashboards more user-friendly and informative. Another significant challenge was the high cost of ArcGIS dashboards, with Esri’s licensing model requiring on average $550 per user annually. Recognizing this financial burden, the team attempted to negotiate a reduced price with Esri. However, their efforts were unsuccessful due to the requirement for a larger number of user accounts to qualify for discounted rates. Despite this, the authors noted that such negotiations could be revisited in the future, especially for organizations with larger teams or those willing to explore collaborative licensing agreements.

By employing these solutions, streamlining variables, leveraging geographic data, targeting specific subsets of data, labeling missing values, investing in self-learning, and attempting cost negotiations, the authors successfully mitigated the challenges they faced. These adaptations not only optimized the dashboard’s performance but also improved its usability and accessibility, offering valuable lessons for others navigating similar obstacles. Their experience highlights the importance of creative problem solving, continuous learning, and strategic planning in the design and implementation of ArcGIS GIS dashboards.

Shiny dashboard. The team also faced several challenges while developing a Shiny dashboard, which required creative solutions and a commitment to learning. One significant difficulty was the steep learning curve, as Shiny development demands not only proficiency in R programming but also familiarity with web technologies like HTML, CSS, and JavaScript. Advanced features further required a deep understanding of reactive programming and Shiny’s underlying infrastructure, making it challenging for those new to these areas. To build their expertise, the team relied on YouTube tutorials, which provided accessible, step-by-step guidance on Shiny development. This hands-on approach was supplemented with extensive reading of documentation and articles, enabling the team to enhance their skills and confidently navigate complex functionalities. Performance optimization was another hurdle, particularly creating intricate visualizations. Deployment and sharing also posed challenges, as hosting on platforms like ShinyApps.io or Shiny Server required careful management of server configurations, security protocols, and user access controls. Additionally, integrating the app with external systems or APIs required extra technical configuration. To address hosting concerns, the team set up their own Shiny server on DigitalOcean 43 providing more flexibility and control over the deployment process. This solution also proved cost-effective, with an average monthly expense of $30 for server maintenance, making it a sustainable choice compared to other hosting options.

Impact of the work. The GIS web-based dashboards developed for the ATLAS dataset from the 83 countries, Kenya and Uganda, and the simulated dataset from Kampala provide essential tools for exploring and visualizing AMR data, especially in Sub-Saharan Africa. Many public health institutions in Sub-Saharan Africa face significant challenges in handling large AMR datasets due to computational constraints and skills gaps. Many researchers work with low-specification computers that struggle with large datasets, causing Excel’s performance to degrade when processing hundreds of thousands of rows. Additionally, the lack of advanced Excel training among AMR researchers results in inefficient workflows that rely on repetitive manual filtering and multi-step processes. These limitations hinder the rapid extraction of actionable insights in public health data. Addressing these challenges requires more efficient data processing tools and capacity-building initiatives to enhance analytical proficiency.

Conclusion and limitations of the study

The development of interactive GIS dashboards using Esri ArcGIS and Shiny platforms offers tool for AMR visualization for Sub-Saharan Africa by allowing users to explore geographic and temporal trends in AMR data. However, several challenges were encountered during the development process. In the case of Esri ArcGIS dashboards, the platform's complexity and the steep learning curve presented significant hurdles, particularly for users with limited GIS experience. The large size of datasets, such as the ATLAS dataset, also posed problems, resulting in slow rendering and processing times, requiring optimization strategies like data aggregation. Additionally, the limited customization options and the high cost of Esri’s subscription model, create accessibility barriers for smaller organizations. Mobile optimization and managing user permissions also added complexity to the dashboard development process. Similarly, Shiny dashboards presented challenges, including the steep learning curve associated with R programming and web development. Deployment and sharing via platforms like ShinyApps.io also required managing server configurations and user access, presenting challenges for those without advanced web development skills. Integrating Shiny with external systems or APIs further increased the complexity of the development process. The study also highlights the scarcity and inconsistencies in ATLAS AMR data, particularly in Africa, where limited sample sizes and variability in data collection across regions like Uganda and Kenya reduce the reliability and generalizability of the dashboards. The dashboards, therefore, depend on standardized data collection practices, improved laboratory capabilities, and greater investment in healthcare infrastructure to fully realize their potential in addressing AMR in Africa.

Funding Statement

This work was supported by Wellcome [227486].

The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.

[version 4; peer review: 2 approved, 1 approved with reservations, 2 not approved]

Data availability

The ATLAS dataset cannot be made available as it is under license by a third party. However, the dataset can be requested from Vivli 44 using the following information:- Data contributor name: Pfizer (AMR); DOI: https://doi.org/10.25934/PR00007930; AMR ID: VIV00007930; and Dataset ID: ATLAS_Antibiotics

The dataset for Objective 1, Supplementary_Table_2.xlsx is available for download at GitHub in the following 30 , similarly, dataset for Objective 2, Supplementary_Table_3.xlsx.zip 31 , is available at GitHub at 30, and dataset for Objective 3, Supplementary_Table_4.xlsx, is available at GitHub 32 . This publication is based on research using data from Pfizer, obtained through 44 .

The dashboard creation codes for Objectives 1 and 2 are not available, as the dashboards were originally constructed using the graphical user interface (GUI) on ArcGIS. To replicate the dashboards, we can leverage open-source QGIS GIS software ( https://qgis.org/en/site/), utilizing the information outlined in the materials and methods section. The R Shiny app call “app.R” for creating dashboard for Objective 3 is available at GitHub in 45, and information about the Shiny app and instructions for installing the app is available in RMarkdown format, pdf format, and html format at GitHub in 46.

References

Wellcome Open Res. 2025 Mar 15. doi: 10.21956/wellcomeopenres.26371.r120300

Reviewer response for version 4

Simon Reid 1

The authors have addressed my comments well. I think the paper makes a worthy contribution to the field.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

I have epidemiological expertise in animal and public health, with a specific emphasis on the analysis, design and use of surveillance data/systems. I have a particular interest in the systems and processes associated with decision-making in public health.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Wellcome Open Res. 2025 Mar 12. doi: 10.21956/wellcomeopenres.26371.r120298

Reviewer response for version 4

Liam P Shaw 1

Thanks to the authors for their responses and revisions. I think the way the study is presented now avoids misrepresenting the work undertaken. I also think that the authors' conclusions and assessments are now more clearly presented in the restructured results and discussion.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Partly

Are all the source data underlying the results available to ensure full reproducibility?

Partly

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

No

Reviewer Expertise:

I am a computational biologist. Previously I have written my own article arising from a data reuse challenge on AMR (https://wellcomeopenresearch.org/articles/4-86) and also peer reviewed another article from a data reuse challenge authored by Quentin Leclerc and others (https://wellcomeopenresearch.org/articles/4-140).

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard.

Wellcome Open Res. 2025 Feb 25. doi: 10.21956/wellcomeopenres.26004.r117159

Reviewer response for version 3

Liam P Shaw 1

I have read the article again. The authors have made positive changes, such as citing previous work on AMR dashboards in their introduction, including a new supplementary table, and including descriptions of the work they did. I am sorry to say that I cannot approve the study in its current state. 

This is no comment on the work, but because the authors still do not seem to have taken onboard the comments of the peer reviewers about their description of the study being inaccurate. For example, in the abstract they still state that they were "simplifying data interpretation for diverse users and supporting informed decision-making processes", which implies (to me) that the study somehow looked at decision-making processes. But it didn't. 

Reading their most recent responses, I think that this is just a fundamental disagreement between the authors and their reviewers. For example, the authors write in their response to my review that their dashboard "significantly improv[es] the user experience by eliminating the need for tedious scrolling and searching through the ATLAS dataset, which contains over 860,000 rows of isolates and 134 columns of variables." But this is arguably a strawman since the ATLAS dataset is, for many people, available via an existing dashboard https://atlas-surveillance.com/. And as Simon Reid's most recent review points out, many of these features are easily available in spreadsheets: even if downloaded as a spreadsheet then "scrolling and searching" is not required - one can just use a filter on a column. 

I commend the authors on their work. But they seem committed to the way they have presented their results when different reviewers have expressed similar concerns. That is their prerogative. The advantage of a platform like Wellcome Open Research is that other people can read their article as it is and make up their own minds.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Partly

Are all the source data underlying the results available to ensure full reproducibility?

Partly

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

No

Reviewer Expertise:

I am a computational biologist. Previously I have written my own article arising from a data reuse challenge on AMR (https://wellcomeopenresearch.org/articles/4-86) and also peer reviewed another article from a data reuse challenge authored by Quentin Leclerc and others (https://wellcomeopenresearch.org/articles/4-140).

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

Wellcome Open Res. 2025 Feb 27.
Stephen Opiyo 1

I have read the article again. The authors have made positive changes, such as citing previous work on AMR dashboards in their introduction, including a new supplementary table, and including descriptions of the work they did. I am sorry to say that I cannot approve the study in its current state.

Reviewer's comments This is no comment on the work, but because the authors still do not seem to have taken onboard the comments of the peer reviewers about their description of the study being inaccurate. For example, in the abstract they still state that they were "simplifying data interpretation for diverse users and supporting informed decision-making processes", which implies (to me) that the study somehow looked at decision-making processes. But it didn't.

Response to Reviewer Based on your suggestion, we have revised the results section of the abstract to enhance clarity and conciseness. Specifically, we have removed the phrase "simplifying data interpretation for diverse users and supporting informed decision-making processes” as requested while ensuring the key findings remain effectively conveyed. The updated results section now reads as follows: Sub-Saharan Africa faces three major challenges in handling antimicrobial resistance (AMR) data: limited accessibility for non-technical users, inefficiencies in processing large datasets, and insufficient longitudinal data for analysis. The introduction of interactive dashboards significantly improved AMR data visualization and interpretation across different scales. The global AMR dashboard effectively mapped geographical trends, uncovering critical data gaps, particularly the scarcity of AMR records from Africa. The Kenya and Uganda dashboard revealed key resistance patterns, highlighting the ineffectiveness of Ceftriaxone, Erythromycin, Levofloxacin, and Ampicillin against E. coli isolates. Additionally, the Kampala-specific dashboard, developed using simulated data, demonstrated the potential for localized AMR visualization, providing valuable insights where real-world data is limited. Across all platforms, the dashboards' interactive features enhanced data accessibility and streamlined trend identification, making AMR insights more interpretable, especially for researchers in Sub-Saharan Africa.

Reviewer’s comments Reading their most recent responses, I think that this is just a fundamental disagreement between the authors and their reviewers. For example, the authors write in their response to my review that their dashboard "significantly improv[es] the user experience by eliminating the need for tedious scrolling and searching through the ATLAS dataset, which contains over 860,000 rows of isolates and 134 columns of variables." But this is arguably a strawman since the ATLAS dataset is, for many people, available via an existing dashboard https://atlas-surveillance.com/. And as Simon Reid's most recent review points out, many of these features are easily available in spreadsheets: even if downloaded as a spreadsheet then "scrolling and searching" is not required - one can just use a filter on a column.

Response to Reviewer

Addressing the perceived "Strawman" Argument We acknowledge the fundamental disagreement between our position and the reviewers' perspective on the necessity and added value of our dashboards. While we appreciate the points raised, we maintain that our approach offers distinct advantages over existing Excel-based workflows and the ATLAS dashboard, particularly in the context of AMR data usability in Sub-Saharan Africa. Our response clarifies these distinctions and highlights the practical challenges faced by researchers in low-resource settings. Some of the authors are from Africa, and our approach is grounded in the realities of data accessibility, computational infrastructure, and public health needs in the region. Limited African representation in ATLAS

  • ATLAS includes data from only 13 out of 55 African countries, leaving out critical regions where AMR surveillance is needed.

  • Some of these 13 countries have only two years of data, significantly limiting the ability to analyze trends and develop meaningful interventions.

  • In contrast, countries like the UK have AMR data dating back to 2004, providing a longitudinal dataset for deeper epidemiological analysis.

  • This data gap disadvantages African researchers and policymakers, forcing reliance on fragmented data or global datasets that do not accurately represent local resistance patterns.

Excel’s limitations in sub-Saharan Africa

  • Computing constraints and large dataset handling: Many institutions operate on low-specification computers that struggle with large datasets. Excel’s performance degrades significantly when handling AMR datasets with hundreds of thousands of rows.

  • Skills and training gaps: Many AMR researchers in African public health institutions lack advanced Excel training and rely on basic functionalities. The need for repeated manual filtering and multi-step workflows creates inefficiencies, making it difficult for public health professionals to quickly extract actionable insights.

Why a custom dashboard is necessary Our dashboard is not just an alternative to Excel filtering, it is a purpose built solution designed to overcome critical limitations faced by researchers in Sub-Saharan Africa.

  1. Bridging data gaps: ATLAS lacks data from most African countries. Our dashboard is specifically designed to integrate and visualize African-specific AMR data, addressing this gap and providing a more comprehensive regional perspective.

  2. Enhancing usability for non-technical users – Unlike Excel, which requires manual filtering and technical expertise, our dashboard features an intuitive interface, making data analysis accessible to researchers without advanced data skills.

  3. Optimizing performance – Large AMR datasets often overwhelm Excel, causing performance issues. Our dashboard efficiently processes complex queries, ensuring smooth analysis without the need for high-end computing resources.

  4. Addressing financial constraints – Many research institutions in Sub-Saharan Africa lack the resources to purchase expensive third-party software like Tableau. Our dashboard provides a cost-effective, open-source alternative without financial barriers.

  Reviewer’s comments I commend the authors on their work. But they seem committed to the way they have presented their results when different reviewers have expressed similar concerns. That is their prerogative. The advantage of a platform like Wellcome Open Research is that other people can read their article as it is and make up their own minds. Response to Reviewer We sincerely appreciate the reviewer’s thoughtful feedback and acknowledge the differences in perspective regarding the necessity and value of our dashboards. While we recognize and respect the concerns raised, we maintain that our approach offers significant advantages over existing Excel-based workflows and the ATLAS dashboard, particularly in the context of AMR data usability in Sub-Saharan Africa. Our response aims to clarify these distinctions and highlight the practical challenges that researchers in low-resource settings face. Some of our authors are from Africa, and our work is directly informed by the realities of data accessibility, computational infrastructure, and public health needs in the region.

Final thoughts We value the open peer-review process and appreciate the opportunity to clarify our position. The advantage of publishing on platforms like Wellcome Open Research is that readers can critically evaluate our work and form their own conclusions. While we acknowledge the differences in opinion, we remain confident that our approach provides a practical and necessary solution for AMR data analysis in African contexts. Once again, we thank the reviewers for their insights, which have helped us furth

Wellcome Open Res. 2025 Jan 27. doi: 10.21956/wellcomeopenres.26004.r117544

Reviewer response for version 3

Simon Reid 1

I agree with other reviewers that this paper presents an interesting and well-developed tool, and that my comments are associated mainly with the presentation of the paper and the interpretation of the results.

The structure of the paper is somewhat confusing because there is no major heading for the results section and no clear discussion section. There appears to be a paragraph of results under the italicised "Statistical analysis" section that is under a sub-heading called "Identification of coordinates". It is not clear what that result presents other than the measurement of variation in the data coverage between regions. 

The fundamental problem I have is that the first two objectives present a discussion of the benefits of the GIS-based platform that only uses a single geographic coordinate based on the capital city. Many of the benefits presented also exist in simple databases such as MS Excel, which has simple and easy to use filtering capabilities, plus visualisation tools in the form of pivot charts and tables that allow exploration, visualisation and some fairly reasonable data analysis. There are also fairly simple data visualisation tools that are commonly used for surveillance dashboards using Tableau, for example. The discussion presented doesn't seek to compare these similar tools with the GIS-based visualisation tool. 

I appreciate that at a higher spatial resolution (Objective 3) there are some benefits in the display of data. However, the study does not perform any spatial analysis only data visualisation. I think the authors need to be clear that the tool does not enable analysis beyond that achievable with simple pivot tables and charts in MS Excel. 

The study would benefit from some information from the perspective of the "decision-makers" who are assumed to need the dashboard. This is necessary before claims of benefits are made.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

I have epidemiological expertise in animal and public health, with a specific emphasis on the analysis, design and use of surveillance data/systems. I have a particular interest in the systems and processes associated with decision-making in public health.

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

Wellcome Open Res. 2025 Feb 27.
Stephen Opiyo 1

Reviwer's comments I agree with other reviewers that this paper presents an interesting and well-developed tool, and that my comments are associated mainly with the presentation of the paper and the interpretation of the results.

The structure of the paper is somewhat confusing because there is no major heading for the results section and no clear discussion section. There appears to be a paragraph of results under the italicised "Statistical analysis" section that is under a sub-heading called "Identification of coordinates". It is not clear what that result presents other than the measurement of variation in the data coverage between regions.   

Response to Reviewer Thank you for your insightful feedback. We have made substantial revisions to the manuscript to improve clarity and address the structural concerns. Specifically, we have:

  1. Clearly separated the Results and Discussion sections to enhance the logical flow of the paper..

  2. Expanded on the challenges of AMR surveillance in Sub-Saharan Africa and the need for an alternative dashboard to address these gaps.

Addressing the reviewer’s specific concerns 1. Structure of the paper – Results and Discussion separation We acknowledge that the lack of a major heading for the Results section may have contributed to structural ambiguity. In the revised version, we have clearly delineated the Results and Discussion sections.

  • The  Results section now presents an explicit analysis of data distribution across regions, highlighting the disparities in AMR data representation in Sub-Saharan Africa compared to high-income countries.

  • The  Discussion section contextualizes these findings, addressing the limitations of existing datasets (e.g., ATLAS) and the challenges posed by using Excel for AMR surveillance in low-resource settings.

2. Results presentation – ATLAS Dataset and African representation We have clarified the statistical results related to data representation:

  • Over the last  18 years, ATLAS has maintained  comprehensive AMR data collection for developed nations, whereas Sub-Saharan African data remains fragmented and inconsistent.

  • ATLAS includes only  13 out of 55 African countries, leaving large gaps in AMR surveillance across the continent.

  • Even within these  13 African countries, data collection is sporadic. For example:
    • Egypt: Data was collected only from  2011 to 2013.
    • Nigeria: Data was available only for  2013–2014 and 2018–2021, with significant gaps between  2004–2012 and 2015–2017.
    • In contrast, the  United Kingdom has data spanning 2004 to 2021, allowing for longitudinal epidemiological analysis.
  • Of the  800,000+ isolates in ATLAS, only  22,000 isolates originated from Africa, demonstrating the scale of underrepresentation.

These findings underscore why AMR research in Africa is severely constrained by incomplete datasets, necessitating alternative.

Reviewer’s Comments

The fundamental problem I have is that the first two objectives present a discussion of the benefits of the GIS-based platform that only uses a single geographic coordinate based on the capital city. Many of the benefits presented also exist in simple databases such as MS Excel, which has simple and easy to use filtering capabilities, plus visualisation tools in the form of pivot charts and tables that allow exploration, visualisation and some fairly reasonable data analysis. There are also fairly simple data visualisation tools that are commonly used for surveillance dashboards using Tableau, for example. The discussion presented doesn't seek to compare these similar tools with the GIS-based visualisation tool. 

Response to Reviewer We appreciate the reviewer’s feedback and recognize the importance of clarifying the distinctions between our GIS-based platform and existing data visualization tools such as MS Excel and Tableau. Our response clarifies these differences and highlights the practical challenges faced by researchers in low-resource settings. Some of the authors are from Africa, and our approach is grounded in the realities of data accessibility, computational infrastructure, and public health needs in the region. 1. The GIS-based platform vs. MS Excel and Tableau We acknowledge that tools such as  Excel and Tableau provide data filtering and visualization capabilities; however, they do not fully address the core challenges faced in AMR data analysis in  Sub-Saharan Africa.

  • Excel’s Limitations in Sub-Saharan Africa:
    • Computing constraints and large dataset handling: Many African institutions operate on low-specification computers that struggle with large AMR datasets. Excel’s performance significantly degrades when handling datasets with hundreds of thousands of rows.
    • Skills and training gaps: Many AMR researchers in African public health institutions lack advanced Excel training, relying on basic functionalities. The need for repeated manual filtering and multi-step workflows makes it difficult to extract actionable insights efficiently.
    • Lack of geographic context: Excel lacks geospatial analytics, limiting the ability to analyze AMR trends based on geographical distribution.
  • Tableau’s financial and accessibility barriers:
    • High Cost: Tableau is an expensive commercial software, making it inaccessible to many institutions in  low-income countries where AMR surveillance is most needed.
    • Data integration issues: While Tableau provides visualization tools, it does not inherently integrate multiple AMR surveillance sources or accommodate the inconsistent reporting structures present in African datasets.
    • Technical expertise requirement: Unlike our  custom-built dashboard, Tableau requires training to use effectively, which may not be feasible for all public health professionals.

2. Why our GIS-based platform is necessary Our dashboard is not simply an alternative to existing tools but a  purpose-built solution designed to overcome the limitations faced by researchers in Sub-Saharan Africa:

  • Bridging data gaps: ATLAS includes data from only  13 out of 55 African countries, with some of these countries having only  two years of data. Our dashboard  integrates African-specific AMR data, addressing the  underrepresentation of the region and providing a  comprehensive regional perspective.

  • Enhancing usability for non-technical users: Unlike  Excel or Tableau, which require manual filtering and technical expertise, our dashboard  features an intuitive interface, making data visualization accessible to researchers without advanced data skills.

  • Optimizing performance: AMR datasets are  large and complex, often exceeding  Excel’s computational capacity. Our  dashboard efficiently processes complex queries, ensuring visualization and presentation  without requiring high-end computing resources.

  • Addressing financial constraints: Many institutions  lack the budget to purchase expensive  third-party software like Tableau. Our dashboard provides a  cost-effective, open-source alternative, eliminating  financial barriers for public health institutions in Africa.

3. Why a GIS-based approach is important Unlike standard database filtering, a GIS-based approach provides  geospatial insights that are critical for AMR surveillance. While some benefits of data filtering exist in Excel or Tableau, our platform provides:

  • Mapping resistance trends across regions, allowing targeted interventions.

  • Identifying geographic hotspots for AMR, which  Excel filtering cannot achieve.

  • Real-time surveillance capabilities, which go beyond  static spreadsheet analysis.

Final adjustments to the manuscript In response to this feedback, we have updated the discussion section to  compare our GIS-based tool with Excel and Tableau, explicitly stating the  advantages of our approach in an African context. These revisions ensure that the  contribution of our platform is clearly articulated while addressing the reviewer’s concerns about alternative tools.

Reviewer’s Comments I appreciate that at a higher spatial resolution (Objective 3) there are some benefits in the display of data. However, the study does not perform any spatial analysis only data visualisation. I think the authors need to be clear that the tool does not enable analysis beyond that achievable with simple pivot tables and charts in MS Excel.   

Response to Reviewer

We have indicated in the text that the tool does not perform spatial analysis.

  Reviewer’s Comments The study would benefit from some information from the perspective of the "decision-makers" who are assumed to need the dashboard. This is necessary before claims of benefits are made.  

Response to Reviewer We appreciate the reviewer’s insightful comment regarding the need for perspectives from decision-makers who are assumed to need the AMR dashboard before making claims about its benefits. We recognize the importance of stakeholder engagement in ensuring that the dashboard is relevant and valuable to those involved in AMR surveillance and decision-making. To this end, we have obtained a formal letter from a key stakeholder, Mr. Sylvester Z. Moyo, Director of Programs at Dynamic Health Systems Initiative (https://github.com/so13839/Team-8952-Vivli-AMR-Competation/blob/main/data/Letter%20of%20Appreciation_AMR%20Dashboard.pdf). In his letter, Mr. Moyo articulates the challenges faced by AMR professionals in Africa, particularly the limitations of existing data management tools like Excel and the high costs of proprietary software such as Tableau and Esri. He highlights the practical benefits of our AMR dashboard, including its ability to handle large datasets, generate real-time visualizations, and provide an accessible, open-source alternative tailored to the needs of African stakeholders. His endorsement underscores the relevance of this dashboard in addressing AMR challenges in resource-limited settings. Furthermore, several of the authors of this study are based in Africa and have direct interactions with stakeholders who recognize the value of dashboards in overcoming data management barriers. Given the widespread AMR challenges across the continent, stakeholders frequently emphasize the need for efficient, cost-effective data visualization tools to support evidence-based decision-making. These interactions have informed the development of the dashboard, ensuring that it meets real-world needs and enhances AMR data accessibility and usability. Based on this input, we believe that the AMR dashboard presents a meaningful solution that aligns with the needs of decision-makers and researchers working on AMR in Africa. We will continue to engage with stakeholders to refine and expand the dashboard’s functionality to maximize its impact. We appreciate the reviewer’s feedback and remain committed to ensuring that our study is informed by stakeholder perspectives.

Wellcome Open Res. 2024 Dec 13. doi: 10.21956/wellcomeopenres.25363.r112467

Reviewer response for version 2

Liam P Shaw 1

Disclaimer: I have read the other referee's reports before writing my own.

Thanks to the authors for the article and I appreciate the work they did in putting this dashboard together. Unfortunately I have major concerns. I know this can be frustrating but I make these comments in the spirit of constructive feedback. I apologise for any oversights or misunderstandings. 

To summarise, I agree with the serious criticisms raised by Quentin Leclerc in his review. The main problem is that the presentation of the study, particularly in the abstract, is inaccurate: the authors claim that "the study demonstrates that the developed GIS dashboards empower stakeholders". However, it doesn't do this. The same applies to many other statements in the paper. This is not a criticism of the work the authors did do, but of how they have presented it. The authors should accurately describe their work rather than appearing to claim they have done something else. 

I have some minor comments on the various objectives below which relate to how the work itself was performed.

Previous literature

The authors do not cite any previous dashboards in their introduction. But these exist e.g. SMART from Merck. Others can be found by e.g. searching "dashboard antibiotic resistance" on PubMed (15 results). 

Objective 1:

The global dashboard ( https://patira.maps.arcgis.com/apps/dashboards/d89c5b039552464f8f04103f05ac889f) has some features that confuse me. What are the green dots in the map on the right-hand side? I thought these were indicating countries, but if e.g. I zoom in on the UK I see two green dots within its borders. Then if I click on Ireland, there is no green dot on the map within Ireland. The same problem arises for Belgium. I think these are probably quite mundane bugs but they are quite serious if the aim of the dashboard is to display data accurately. It doesn't give me confidence in the dashboard, and raises the question of to what extent Objective 1 has been achieved. I presume these errors arise from the longitude/latitude for capital cities obtained from Wikipedia but since these weren't made available and I'm not sure of the precise source I cannot check (the Wikipedia citation is only for the Wikipedia homepage). 

Regarding the visualization for an individual country e.g. Uganda in Fig. 1b: the authors claim that this is "a visually appealing presentation...simplifying data interpretation, aiding monitoring and evaluation efforts, and providing comprehensive information for hypothesis formulation, particularly emphasizing the examination of the number of isolates and data collection duration in the country". But this confuses me, because these two pieces of information are the only ones available in the display: there are 76 isolates and they were collected in 2021. As far as I'm aware the dashboard presents no other information. Since there isn't any other data to interpret, this is not "comprehensive information for hypothesis formulation". It's hard for me to reconcile what the authors have done with how it has been described. 

Objective 2:

When I try to reproduce Fig 2b by clicking "Escherichia coli" and "Uganda" I get 26 samples rather than 21. I was confused about this inconsistency. Then when I clicked "Resistant" for levofloxacin I could get 21 samples. I think the authors should describe that this is the filtering they did: their figure shows only the E. coli samples from Uganda that were resistant to levofloxacin, which allows a user to see resistance levels for other antibiotics.  

Objective 3:

I don't understand why generating a simulated dataset is the objective. Making a dashboard for hypothetical data at the country level is surely the objective? The simulated data is arbitrary. The link (reference 20) didn't work for me and then I realised that I would need to use the github to reproduce it - that should be made clear rather than saying it's accessible at the link, since it isn't without those steps. 

In summary, unfortunately it is not possible for me to endorse this work given these concerns.

Is the work clearly and accurately presented and does it cite the current literature?

Partly

If applicable, is the statistical analysis and its interpretation appropriate?

Partly

Are all the source data underlying the results available to ensure full reproducibility?

Partly

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

No

Reviewer Expertise:

I am a computational biologist working. I have written my own article arising from a data reuse challenge on AMR (https://wellcomeopenresearch.org/articles/4-86) and also peer reviewed another article from a data reuse challenge authored by Quentin Leclerc and others (https://wellcomeopenresearch.org/articles/4-140).

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

Wellcome Open Res. 2024 Dec 25.
Stephen Opiyo 1

Dear Dr. Liam P. Shaw, Thank you very much for taking the time to review our manuscript. We sincerely appreciate your valuable feedback. We will respond to each of your comments thoroughly. 

Kind regards, 

Stephen  

Reviewer comments Disclaimer: I have read the other referee's reports before writing my own.

Thanks to the authors for the article and I appreciate the work they did in putting this dashboard together. Unfortunately I have major concerns. I know this can be frustrating but I make these comments in the spirit of constructive feedback. I apologise for any oversights or misunderstandings. 

To summarise, I agree with the serious criticisms raised by Quentin Leclerc in his review. The main problem is that the presentation of the study, particularly in the abstract, is inaccurate: the authors claim that "the study demonstrates that the developed GIS dashboards empower stakeholders". However, it doesn't do this. The same applies to many other statements in the paper. This is not a criticism of the work the authors did do, but of how they have presented it. The authors should accurately describe their work rather than appearing to claim they have done something else. 

Response to the Reviewer The abstract has been rewritten to reflect the results discussed in the revised manuscript (see Page 1). Additionally, I have addressed the questions and comments raised by Quentin Leclerc. 

Below are questions and comments raised by Quentin Leclerc and our responses Reviewer comments In this article, the authors present GIS dashboards they designed using data from industry AMR monitoring systems. Such tools can be interesting to visualise AMR data, both for communication and awareness purposes. The design of the dashboards by the authors is appropriate and I have no major concerns about this. Unfortunately, the conclusions of the study are currently too strong and not supported by the analysis. While I agree that GIS dashboard can be useful, here the authors do not directly demonstrate that they empower stakeholders or allow key decisions to be made. In that sense, the “Impact of the work” section of the Discussion is misleading as it discusses the potential usefulness of dashboard as if this was a certainty that had been proven in this article. Additionally, I think that further information should be provided on the datasets used in this project. Overall, I believe this article can be of general interest only if the conclusions are rephrased to appropriately discuss the potential usefulness of GIS dashboards as well as their limitations. Additionally, I think that the paper would be greatly enhanced by the authors’ perspective on designing such a dashboard: which obstacles did they encounter? How have they adapted their approach? Do they have any recommendations? These questions would be of interest to the scientific community. If such changes are implemented, I would be happy to update my review. Response to the Reviewer

Datasets and dashboards We have clarified and expanded on the datasets used for developing the dashboards: Supplementary Table 2: Dataset for the Objective 1 dashboard. Supplementary Table 3: Dataset for dashboards developed for Objective 2. Supplementary Table 4: Dataset for creating the Objective 3 dashboard. These datasets have been made publicly available for transparency and reproducibility via GitHub at https://github.com/so13839/Team-8952-Vivli-AMR-Competation/tree/main/data. References 30 to 32 in the revised manuscript now correspond to these datasets. Impact of the Work We have revised the “Impact of the Work” section to provide greater emphasis on the dashboards' usability and significance:   The GIS web-based dashboards developed for the ATLAS dataset, covering 83 countries, and the dashboards for Kenya, Uganda, and simulated data from Kampala provide essential tools for exploring and analyzing AMR data. These dashboards are designed to offer a user-friendly, interactive interface tailored to researchers, technicians, and healthcare professionals. The dashboards allow filtering and segmenting of data by key variables, such as country, species, sample sources, and antibiotic resistance profiles. For instance, the Uganda and Kenya dashboards highlight resistance patterns for E. coli and visualize data distributions by sample source, year, and resistance levels for antibiotics such as Ampicillin, Levofloxacin, and Imipenem. In Kampala, the simulated dataset provides a focused view, enabling users to identify areas with limited data and prioritize research. Missing data is clearly labeled as “No Information,” helping to highlight gaps requiring further investigation. This interactive approach offers significant improvements over traditional spreadsheet analysis by uncovering spatial and temporal trends efficiently and enabling informed decision-making. Conclusions and Limitations of the Study We have rephrased the conclusions to emphasize the dashboards’ potential while addressing their limitations: The interactive GIS dashboards developed using Esri ArcGIS and Shiny represent a significant improvement over spreadsheets, enabling efficient exploration of geographic and temporal trends in AMR data. However, several challenges were encountered. For Esri ArcGIS dashboards, these included the platform's complexity, steep learning curve, and the large dataset size, which required optimization strategies such as data aggregation to improve performance. Limited customization options and the high subscription costs of Esri tools also posed barriers, especially for smaller organizations. Shiny dashboards presented challenges such as the steep learning curve of R programming, deployment complexities, and integration with external APIs. Managing server configurations for platforms like ShinyApps.io required advanced technical skills. Additionally, the study highlights the limitations in AMR data availability, particularly in Africa. Data scarcity, limited sample sizes, and inconsistencies in data collection practices across Uganda and Kenya reduce the dashboards’ reliability. To address these challenges and enhance the dashboards’ effectiveness, we recommend standardized data collection practices, investment in laboratory infrastructure. These steps will ensure the dashboards’ full potential is realized in combating AMR in Africa.

Reviewer comments

Introduction

The Introduction can be refocused on the topic of the study – for example, although I agree they are important, the concepts of One Health and antibiotic consumption in animals are not directly relevant in this work. Instead, it would be more relevant for you to introduce GIS dashboards in greater detail – why did the OHE-AMURS work so well? Are there any limitations? How could dashboards be useful in Nepal? By focusing on GIS dashboards before the Objectives section, the scope of the article will be much clearer for readers. Response to the Reviewer We have revised the manuscript by removing references to One Health and antibiotic consumption in animals. Instead, we have introduced Geographic Information Systems (GIS) and an Interactive GIS Dashboard as central components of the study. Additionally, we have addressed all the reviewer’s comments in the Introduction, specifically within paragraphs 2 to 5 of the revised manuscript.

Reviewer comments Objectives

It is not clear here what you mean by “descriptive statistical analysis”. If this refers to the beginning of your Results section, it is a bit hard to follow, as it explains the conclusions before the results. I understand you may be describing your exact work process during the Vivli Data Challenge, but for readers this will not be clear. You could simply state here that you observed data gaps in African countries and that this motivated your three objectives.

Throughout: you used the ATLAS dataset in your analysis, so please correct any references to the data accordingly. For example, “the Vivli dataset” is not accurate, since Vivli only facilitate access to the data, but do not own it.

Objective 3 needs to be clarified. It is not obvious what you mean by “simulated dataset” here, how this may be useful, and what is the link with Kampala, Uganda.  

Response to the Reviewer We have removed the descriptive statistical analysis and highlighted the observation of data gaps in African countries in the revised manuscript. Additionally, the Vivli dataset has been replaced with the ATLAS dataset. Objective 3 has been rewritten as: 'To demonstrate the potential usefulness and design of a dashboard that facilitates the analysis of antimicrobial resistance (AMR) patterns in Kampala, Uganda.'"

Reviewer comments

Methods

Further information needs to be provided on the ATLAS dataset which you used to inform the dashboards, otherwise readers cannot understand the context and generalisability of the work. For example: how were isolates collected, what is the purpose of this data, which variables does it contain, which biases could it be exposed to... This has been discussed in previous articles which I have referenced below.

Response to the Reviewer We have incorporated a discussion of the ATLAS dataset in the revised manuscript, detailing the methods used for isolate collection and referencing previous studies that analyzed this data. Please refer to the section titled Pfizer ATLAS Dataset on page 4 of the revised manuscript.

Reviewer comments

Results

Here already, you should adjust the phrasing on the usefulness of GIS dashboards. Here, since you do not directly demonstrate the usefulness of dashboards, you can only discuss their potential value. For example, “is a valuable tool for researchers, policymakers and healthcare professionals” is not supported by the analysis.

Response to the Reviewer We have carefully revised the section as per your feedback. The updated section can now be found on page 6 of the revised manuscript. This revision incorporates the necessary clarifications and aligns with the overarching goals of the study. We believe these changes enhance the manuscript's clarity and relevance. If additional adjustments or further clarifications are required, we are happy to address them.  

Reviewer comments

In Objective 2, it is not clear what you mean by “comparative analysis and focused investigations”.  

Response to the Reviewer We have carefully addressed your comment and have rewritten and clarified the content in Objective 2, which can now be found on page 6 of the revised manuscript.

Reviewer comments For Objective 3 here again it is very unclear what the “simulated dataset” corresponds to and how it was generated. If it is simulated, then interpreting susceptibility results for  K. aerogenes does not make sense. If the point here is to demonstrate the potential usefulness and design of a dashboard using this type of data, then it should be presented as such.  

Response to the Reviewer We have revised the objective to clarify that the simulated dataset is intended to demonstrate how the dashboard could be applied to Kampala, Uganda. The Shiny dashboard created using this simulated data is for illustrative purposes only. The primary intention is to showcase the functionality and potential application of the dashboard. We have included this clarification in the revised manuscript, which can be found on page 7.

Reviewer comments

Discussion

A major counter-argument to the use of GIS dashboards is that researchers interested in in-depth analysis would simply obtain the underlying data themselves, rather than use the dashboard. In that sense, you should better discuss the usefulness of dashboards: to whom and how would they be useful exactly? Do you have any examples of dashboards being used in analyses? Are there any previous studies which discussed the potential benefits of GIS dashboards for AMR surveillance? (or for any other surveillance)  

Response to the Reviewer In response to your suggestion, we have emphasized the advantages of using dashboards over spreadsheets, particularly in the context of Objectives 1 to 3. Dashboards offer enhanced data visualization, real-time updates, and more intuitive decision-making compared to traditional spreadsheet approaches. For example, Kenya’s One Health AMR Surveillance System (OHAMRS) integrates human and animal health data to visualize AMR patterns across various sectors, making it easier to detect and respond to emerging threats. Similarly, Switzerland’s Swiss Pathogen Surveillance Platform (SPSP) leverages genomics and metadata for effective outbreak monitoring and data sharing. These case studies demonstrate the value of dashboards in surveillance and their ability to improve the efficiency and accessibility of complex data sets. References 15 and 16 in the revised manuscript have been updated to reflect these examples.

Reviewer comments As mentioned previously, there are several statements in your Discussion which are not supported by your analysis, such as “The dashboard acts as a centralized hub, aggregating and organizing these datasets for easy access and analysis.” which is not the case here since (if I understood correctly) you only used the ATLAS dataset; “complex queries” are not demonstrated since you present only filtering commands; “examine the impact of different policies or interventions in specific countries, evaluate the effectiveness of existing strategies” policies and interventions are not implemented in the dashboard; “healthcare outcomes” are not included in the dashboard.  

Response to the Reviewer We have revised the Impact of the Work and Conclusions sections to better reflect the findings of our study. The updated content can be found on pages 9 to 10 of the revised manuscript. We believe these revisions provide a clearer and more accurate representation of the implications of our results.  

Response to Dr. Liam P. Shaw continued

I have some minor comments on the various objectives below which relate to how the work itself was performed.

Reviewer comments Previous literature

The authors do not cite any previous dashboards in their introduction. But these exist e.g. SMART from Merck. Others can be found by e.g. searching "dashboard antibiotic resistance" on PubMed (15 results). 

Response to the Reviewer We have included additional literature in the Introduction section of the revised manuscript, specifically in paragraph 4, page 3. This new content references previous work on dashboards related to Antimicrobial Resistance (AMR), as indicated by references 13 to 21. These references discuss the development and application of AMR dashboards, providing insights into their role in data visualization, surveillance, and decision-making.

Reviewer comments Objective 1:

The global dashboard ( https://patira.maps.arcgis.com/apps/dashboards/d89c5b039552464f8f04103f05ac889f) has some features that confuse me. What are the green dots in the map on the right-hand side? I thought these were indicating countries, but if e.g. I zoom in on the UK I see two green dots within its borders. Then if I click on Ireland, there is no green dot on the map within Ireland. The same problem arises for Belgium. I think these are probably quite mundane bugs but they are quite serious if the aim of the dashboard is to display data accurately. It doesn't give me confidence in the dashboard, and raises the question of to what extent Objective 1 has been achieved. I presume these errors arise from the longitude/latitude for capital cities obtained from Wikipedia but since these weren't made available and I'm not sure of the precise source I cannot check (the Wikipedia citation is only for the Wikipedia homepage). 

Response to the Reviewer The green dots indicate countries. We have corrected the error on the map, and now when you click on the green dot representing a country, the name of the country is displayed. The longitude and latitude used to create the dashboard are provided in Supplementary Table 2 for reference.

Reviewer comments

Regarding the visualization for an individual country e.g. Uganda in Fig. 1b: the authors claim that this is "a visually appealing presentation...simplifying data interpretation, aiding monitoring and evaluation efforts, and providing comprehensive information for hypothesis formulation, particularly emphasizing the examination of the number of isolates and data collection duration in the country". But this confuses me, because these two pieces of information are the only ones available in the display: there are 76 isolates and they were collected in 2021. As far as I'm aware the dashboard presents no other information. Since there isn't any other data to interpret, this is not "comprehensive information for hypothesis formulation". It's hard for me to reconcile what the authors have done with how it has been described.   

Response to the Reviewer The dashboard is designed to allow users to dynamically filter Uganda from the 83 countries in the ATLAS dataset, significantly improving the user experience by eliminating the need for tedious scrolling and searching through the ATLAS dataset, which contains over 860,000 rows of isolates and 134 columns of variables.

Reviewer comments

Objective 2:

When I try to reproduce Fig 2b by clicking "Escherichia coli" and "Uganda" I get 26 samples rather than 21. I was confused about this inconsistency. Then when I clicked "Resistant" for levofloxacin I could get 21 samples. I think the authors should describe that this is the filtering they did: their figure shows only the  E. coli samples from Uganda that were resistant to levofloxacin, which allows a user to see resistance levels for other antibiotics.  

Response to the Reviewer In response to your comment, we have revised the manuscript to clarify the filtering process used in our analysis. Specifically, the figure now highlights only the E. coli samples from Uganda, revealing that Ampicillin, Levofloxacin, and Ciprofloxacin were ineffective in 21 samples, which were classified as Resistant. Conversely, Imipenem was effective across all 21 samples, which were classified as Susceptible. This updated explanation is provided in Figure 2B on page 7 of the revised manuscript.

Reviewer comments Objective 3:

I don't understand why generating a simulated dataset is the objective. Making a dashboard for hypothetical data at the country level is surely the objective? The simulated data is arbitrary. The link (reference 20) didn't work for me and then I realised that I would need to use the github to reproduce it - that should be made clear rather than saying it's accessible at the link, since it isn't without those steps. 

Response to the Reviewer We have revised Objective 3 to better reflect the purpose of the Objective. Initially, the objective aimed to demonstrate the functionality of the dashboard in Kampala, Uganda, specifically addressing the challenges posed by the limited availability of AMR datasets. To overcome this, we simulated a dataset to ensure the dashboard’s functionality could still be showcased. However, following your suggestion, we have reworded the objective to focus on demonstrating the functionality of the interactive GIS dashboard itself. This revision highlights the dashboard's capabilities in visualizing and analyzing antimicrobial resistance (AMR) data, regardless of dataset limitations, by leveraging both real and simulated data. We believe this approach more accurately conveys the core aim of the study.

Wellcome Open Res. 2024 Dec 7. doi: 10.21956/wellcomeopenres.25363.r111333

Reviewer response for version 2

Quentin Leclerc 1,1

In this article, the authors present GIS dashboards they designed using data from industry AMR monitoring systems. Such tools can be interesting to visualise AMR data, both for communication and awareness purposes. The design of the dashboards by the authors is appropriate and I have no major concerns about this. Unfortunately, the conclusions of the study are currently too strong and not supported by the analysis. While I agree that GIS dashboard can be useful, here the authors do not directly demonstrate that they empower stakeholders, or allow key decisions to be made. In that sense, the “Impact of the work” section of the Discussion is misleading as it discusses the potential usefulness of dashboard as if this was a certainty that had been proven in this article. Additionally, I think that further information should be provided on the datasets used in this project. Overall, I believe this article can be of general interest only if the conclusions are rephrased to appropriately discuss the potential usefulness of GIS dashboards as well as their limitations. Additionally, I think that the paper would be greatly enhanced by the authors’ perspective on designing such a dashboard: which obstacles did they encounter? How have they adapted their approach? Do they have any recommendations? These questions would be of interest to the scientific community. If such changes are implemented, I would be happy to update my review. My comments addressed to the authors are listed below.

Introduction

The Introduction can be refocused on the topic of the study – for example, although I agree they are important, the concepts of One Health and antibiotic consumption in animals are not directly relevant in this work. Instead, it would be more relevant for you to introduce GIS dashboards in greater detail – why did the OHE-AMURS work so well? Are there any limitations? How could dashboards be useful in Nepal? By focusing on GIS dashboards before the Objectives section, the scope of the article will be much clearer for readers.

Objectives

It is not clear here what you mean by “descriptive statistical analysis”. If this refers to the beginning of your Results section, it is a bit hard to follow, as it explains the conclusions before the results. I understand you may be describing your exact work process during the Vivli Data Challenge, but for readers this will not be clear. You could simply state here that you observed data gaps in African countries and that this motivated your three objectives.

Throughout: you used the ATLAS dataset in your analysis, so please correct any references to the data accordingly. For example, “the Vivli dataset” is not accurate, since Vivli only facilitate access to the data, but do not own it.

Objective 3 needs to be clarified. It is not obvious what you mean by “simulated dataset” here, how this may be useful, and what is the link with Kampala, Uganda.

Methods

Further information needs to be provided on the ATLAS dataset which you used to inform the dashboards, otherwise readers cannot understand the context and generalisability of the work. For example: how were isolates collected, what is the purpose of this data, which variables does it contain, which biases could it be exposed to... This has been discussed in previous articles which I have referenced below.

Results

Here already, you should adjust the phrasing on the usefulness of GIS dashboards. Here, since you do not directly demonstrate the usefulness of dashboards, you can only discuss their potential value. For example, “is a valuable tool for researchers, policymakers and healthcare professionals” is not supported by the analysis.

In Objective 2, it is not clear what you mean by “comparative analysis and focused investigations”.

For Objective 3 here again it is very unclear what the “simulated dataset” corresponds to and how it was generated. If it is simulated, then interpreting susceptibility results for K. aerogenes does not make sense. If the point here is to demonstrate the potential usefulness and design of a dashboard using this type of data, then it should be presented as such.

Discussion

A major counter-argument to the use of GIS dashboards is that researchers interested in in-depth analysis would simply obtain the underlying data themselves, rather than use the dashboard. In that sense, you should better discuss the usefulness of dashboards: to whom and how would they be useful exactly? Do you have any examples of dashboards being used in analyses? Are there any previous studies which discussed the potential benefits of GIS dashboards for AMR surveillance? (or for any other surveillance)

As mentioned previously, there are several statements in your Discussion which are not supported by your analysis, such as “The dashboard acts as a centralized hub, aggregating and organizing these datasets for easy access and analysis.” which is not the case here since (if I understood correctly) you only used the ATLAS dataset; “complex queries” are not demonstrated since you present only filtering commands; “examine the impact of different policies or interventions in specific countries, evaluate the effectiveness of existing strategies” policies and interventions are not implemented in the dashboard; “healthcare outcomes” are not included in the dashboard.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Partly

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

No

Are sufficient details of methods and analysis provided to allow replication by others?

No

Reviewer Expertise:

My research is focused on the dynamics of AMR. I have previously worked with industry AMR monitoring systems, including the ATLAS dataset used in this study (see https://wellcomeopenresearch.org/articles/4-140 and https://wellcomeopenresearch.org/articles/9-248). I won three prizes in the context of data challenges involving these datasets (2019, 2023, 2024).

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

References

  • 1. : Seeking patterns of antibiotic resistance in ATLAS, an open, raw MIC database with patient metadata. Nat Commun .2022;13(1) : 10.1038/s41467-022-30635-7 2917 10.1038/s41467-022-30635-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. : Determinants of worldwide antibiotic resistance dynamics across drug-bacterium pairs: a multivariable spatial-temporal analysis using ATLAS. Lancet Planet Health .2023;7(7) : 10.1016/S2542-5196(23)00127-4 e547-e557 10.1016/S2542-5196(23)00127-4 [DOI] [PubMed] [Google Scholar]
Wellcome Open Res. 2024 Dec 25.
Stephen Opiyo 1

Dear Dr. Quentin Leclerc, Thank you very much for taking the time to review our manuscript. We sincerely appreciate your valuable feedback. We will respond to each of your comments thoroughly. 

Kind regards, 

Stephen  

Reviewer comments In this article, the authors present GIS dashboards they designed using data from industry AMR monitoring systems. Such tools can be interesting to visualise AMR data, both for communication and awareness purposes. The design of the dashboards by the authors is appropriate and I have no major concerns about this. Unfortunately, the conclusions of the study are currently too strong and not supported by the analysis. While I agree that GIS dashboard can be useful, here the authors do not directly demonstrate that they empower stakeholders or allow key decisions to be made. In that sense, the “Impact of the work” section of the Discussion is misleading as it discusses the potential usefulness of dashboard as if this was a certainty that had been proven in this article. Additionally, I think that further information should be provided on the datasets used in this project. Overall, I believe this article can be of general interest only if the conclusions are rephrased to appropriately discuss the potential usefulness of GIS dashboards as well as their limitations. Additionally, I think that the paper would be greatly enhanced by the authors’ perspective on designing such a dashboard: which obstacles did they encounter? How have they adapted their approach? Do they have any recommendations? These questions would be of interest to the scientific community. If such changes are implemented, I would be happy to update my review. Response to the Reviewer Datasets and dashboards We have clarified and expanded on the datasets used for developing the dashboards: Supplementary Table 2: Dataset for the Objective 1 dashboard. Supplementary Table 3: Dataset for dashboards developed for Objective 2. Supplementary Table 4: Dataset for creating the Objective 3 dashboard. These datasets have been made publicly available for transparency and reproducibility via GitHub at https://github.com/so13839/Team-8952-Vivli-AMR-Competation/tree/main/data. References 30 to 32 in the revised manuscript now correspond to these datasets. Impact of the Work We have revised the “Impact of the Work” section to provide greater emphasis on the dashboards' usability and significance:   The GIS web-based dashboards developed for the ATLAS dataset, covering 83 countries, and the dashboards for Kenya, Uganda, and simulated data from Kampala provide essential tools for exploring and analyzing AMR data. These dashboards are designed to offer a user-friendly, interactive interface tailored to researchers, technicians, and healthcare professionals. The dashboards allow filtering and segmenting of data by key variables, such as country, species, sample sources, and antibiotic resistance profiles. For instance, the Uganda and Kenya dashboards highlight resistance patterns for E. coli and visualize data distributions by sample source, year, and resistance levels for antibiotics such as Ampicillin, Levofloxacin, and Imipenem. In Kampala, the simulated dataset provides a focused view, enabling users to identify areas with limited data and prioritize research. Missing data is clearly labeled as “No Information,” helping to highlight gaps requiring further investigation. This interactive approach offers significant improvements over traditional spreadsheet analysis by uncovering spatial and temporal trends efficiently and enabling informed decision-making. Conclusions and Limitations of the Study We have rephrased the conclusions to emphasize the dashboards’ potential while addressing their limitations: The interactive GIS dashboards developed using Esri ArcGIS and Shiny represent a significant improvement over spreadsheets, enabling efficient exploration of geographic and temporal trends in AMR data. However, several challenges were encountered. For Esri ArcGIS dashboards, these included the platform's complexity, steep learning curve, and the large dataset size, which required optimization strategies such as data aggregation to improve performance. Limited customization options and the high subscription costs of Esri tools also posed barriers, especially for smaller organizations. Shiny dashboards presented challenges such as the steep learning curve of R programming, deployment complexities, and integration with external APIs. Managing server configurations for platforms like ShinyApps.io required advanced technical skills. Additionally, the study highlights the limitations in AMR data availability, particularly in Africa. Data scarcity, limited sample sizes, and inconsistencies in data collection practices across Uganda and Kenya reduce the dashboards’ reliability. To address these challenges and enhance the dashboards’ effectiveness, we recommend standardized data collection practices, investment in laboratory infrastructure. These steps will ensure the dashboards’ full potential is realized in combating AMR in Africa.

Reviewer comments

Introduction

The Introduction can be refocused on the topic of the study – for example, although I agree they are important, the concepts of One Health and antibiotic consumption in animals are not directly relevant in this work. Instead, it would be more relevant for you to introduce GIS dashboards in greater detail – why did the OHE-AMURS work so well? Are there any limitations? How could dashboards be useful in Nepal? By focusing on GIS dashboards before the Objectives section, the scope of the article will be much clearer for readers. Response to the Reviewer We have revised the manuscript by removing references to One Health and antibiotic consumption in animals. Instead, we have introduced Geographic Information Systems (GIS) and an Interactive GIS Dashboard as central components of the study. Additionally, we have addressed all the reviewer’s comments in the Introduction, specifically within paragraphs 2 to 5 of the revised manuscript.

Reviewer comments Objectives

It is not clear here what you mean by “descriptive statistical analysis”. If this refers to the beginning of your Results section, it is a bit hard to follow, as it explains the conclusions before the results. I understand you may be describing your exact work process during the Vivli Data Challenge, but for readers this will not be clear. You could simply state here that you observed data gaps in African countries and that this motivated your three objectives.

Throughout: you used the ATLAS dataset in your analysis, so please correct any references to the data accordingly. For example, “the Vivli dataset” is not accurate, since Vivli only facilitate access to the data, but do not own it.

Objective 3 needs to be clarified. It is not obvious what you mean by “simulated dataset” here, how this may be useful, and what is the link with Kampala, Uganda.  

Response to the Reviewer We have removed the descriptive statistical analysis and highlighted the observation of data gaps in African countries in the revised manuscript. Additionally, the Vivli dataset has been replaced with the ATLAS dataset. Objective 3 has been rewritten as: 'To demonstrate the potential usefulness and design of a dashboard that facilitates the analysis of antimicrobial resistance (AMR) patterns in Kampala, Uganda.'"

Reviewer comments

Methods

Further information needs to be provided on the ATLAS dataset which you used to inform the dashboards, otherwise readers cannot understand the context and generalisability of the work. For example: how were isolates collected, what is the purpose of this data, which variables does it contain, which biases could it be exposed to... This has been discussed in previous articles which I have referenced below.

Response to the Reviewer We have incorporated a discussion of the ATLAS dataset in the revised manuscript, detailing the methods used for isolate collection and referencing previous studies that analyzed this data. Please refer to the section titled Pfizer ATLAS Dataset on page 4 of the revised manuscript.

Reviewer comments

Results

Here already, you should adjust the phrasing on the usefulness of GIS dashboards. Here, since you do not directly demonstrate the usefulness of dashboards, you can only discuss their potential value. For example, “is a valuable tool for researchers, policymakers and healthcare professionals” is not supported by the analysis.

Response to the Reviewer We have carefully revised the section as per your feedback. The updated section can now be found on page 6 of the revised manuscript. This revision incorporates the necessary clarifications and aligns with the overarching goals of the study. We believe these changes enhance the manuscript's clarity and relevance. If additional adjustments or further clarifications are required, we are happy to address them.  

Reviewer comments

In Objective 2, it is not clear what you mean by “comparative analysis and focused investigations”.  

Response to the Reviewer We have carefully addressed your comment and have rewritten and clarified the content in Objective 2, which can now be found on page 6 of the revised manuscript.

Reviewer comments For Objective 3 here again it is very unclear what the “simulated dataset” corresponds to and how it was generated. If it is simulated, then interpreting susceptibility results for  K. aerogenes does not make sense. If the point here is to demonstrate the potential usefulness and design of a dashboard using this type of data, then it should be presented as such.  

Response to the Reviewer We have revised the objective to clarify that the simulated dataset is intended to demonstrate how the dashboard could be applied to Kampala, Uganda. The Shiny dashboard created using this simulated data is for illustrative purposes only. The primary intention is to showcase the functionality and potential application of the dashboard. We have included this clarification in the revised manuscript, which can be found on page 7.

Reviewer comments

Discussion

A major counter-argument to the use of GIS dashboards is that researchers interested in in-depth analysis would simply obtain the underlying data themselves, rather than use the dashboard. In that sense, you should better discuss the usefulness of dashboards: to whom and how would they be useful exactly? Do you have any examples of dashboards being used in analyses? Are there any previous studies which discussed the potential benefits of GIS dashboards for AMR surveillance? (or for any other surveillance)  

Response to the Reviewer In response to your suggestion, we have emphasized the advantages of using dashboards over spreadsheets, particularly in the context of Objectives 1 to 3. Dashboards offer enhanced data visualization, real-time updates, and more intuitive decision-making compared to traditional spreadsheet approaches. For example, Kenya’s One Health AMR Surveillance System (OHAMRS) integrates human and animal health data to visualize AMR patterns across various sectors, making it easier to detect and respond to emerging threats. Similarly, Switzerland’s Swiss Pathogen Surveillance Platform (SPSP) leverages genomics and metadata for effective outbreak monitoring and data sharing. These case studies demonstrate the value of dashboards in surveillance and their ability to improve the efficiency and accessibility of complex data sets. References 15 and 16 in the revised manuscript have been updated to reflect these examples.

Reviewer comments As mentioned previously, there are several statements in your Discussion which are not supported by your analysis, such as “The dashboard acts as a centralized hub, aggregating and organizing these datasets for easy access and analysis.” which is not the case here since (if I understood correctly) you only used the ATLAS dataset; “complex queries” are not demonstrated since you present only filtering commands; “examine the impact of different policies or interventions in specific countries, evaluate the effectiveness of existing strategies” policies and interventions are not implemented in the dashboard; “healthcare outcomes” are not included in the dashboard.  

Response to the Reviewer We have revised the Impact of the Work and Conclusions sections to better reflect the findings of our study. The updated content can be found on pages 9 to 10 of the revised manuscript. We believe these revisions provide a clearer and more accurate representation of the implications of our results.

Wellcome Open Res. 2024 Aug 8. doi: 10.21956/wellcomeopenres.23245.r88572

Reviewer response for version 1

Dov Stekel 1,2

This is a very interesting report and the idea of an interactive GIS-enabled AMR tool is very good and has my support.

The most important problem however is the lack of availability of the dashboard creation code and the synthetic data from Objective 3. It is very difficult to see how this idea could be of general use without access either to the code or to the interface: indeed I would expect under FAIR principles there to be much greater availability of the methods.

There are a few minor comments about the way it is written:

  • Methods in Abstract: please rewrite the section to avoid the terms "Objective 1" etc: those terms read like a grant application or project plan and don't really fit the report of a published article.

  • Introduction first paragraph: authors refer to both UTIs and poultry systems - which is fine (if a bit abrupt). It would be helpful if the authors were to introduce the One Health framing first, because then the link between the human and agricultural aspects would be more logical.(I note that One Health is referred to in the next paragraph - what is needed is a short description of the idea in paragraph 1, with citation, and perhaps justification as to why it is especially important in sub-Saharan Africa (and lower income countries more generally  - as implied by the reference to Nepal))

  • Introduction - penaultimate paragraph reads a bit strange - I would suggest deleting that - it is OK to reference the project abstract - but really what we are looking for is a description of the research, not the details of the Vivli data challenge.

  • In Objective 3, the phrase "Specifically, let’s focus" is too colloquial and needs modifying.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

No

Is the study design appropriate and is the work technically sound?

Partly

Are the conclusions drawn adequately supported by the results?

Yes

Are sufficient details of methods and analysis provided to allow replication by others?

No

Reviewer Expertise:

Computational Biology, especially in One Health approaches to AMR

I confirm that I have read this submission and believe that I have an appropriate level of expertise to state that I do not consider it to be of an acceptable scientific standard, for reasons outlined above.

Wellcome Open Res. 2024 Aug 25.
Stephen Opiyo 1

Dear Dr. Stekel,  

Thank you very much for taking the time to review our manuscript. We sincerely appreciate your valuable feedback. We will respond to each of your comments thoroughly. For clarity, your comments will be highlighted in red, while our responses will be indicated in blue.   Kind regards, 

Stephen   Dov   Stekel, University of Johannesburg, Auckland Park, Johannesburg, South Africa; University of Nottingham, Nottingham, England, UK This is a very interesting report and the idea of an interactive GIS-enabled AMR tool is very good and has my support.

Reviewer:

The most important problem however is the lack of availability of the dashboard creation code and the synthetic data from Objective 3. It is very difficult to see how this idea could be of general use without access either to the code or to the interface: indeed I would expect under FAIR principles there to be much greater availability of the methods.

Response to the Reviewer:

We have successfully developed an R Shiny dashboard for Objective 3 and uploaded the corresponding data to GitHub. However, we were unable to develop R Shiny dashboards for Objectives 1 and 2 due to the unavailability of third-party data. Additionally, we cannot provide the code for creating dashboards for Objectives 1 and 2, as they were built in the cloud using Esri’s Graphical User Interface (GUI), which does not generate code for cloud-based dashboards. Nevertheless, the links to these dashboards are available at (https://patira.maps.arcgis.com/apps/dashboards/d89c5b039552464f8f04103f05ac889f ) for Objective 1 and (https://patira.maps.arcgis.com/apps/dashboards/a1324c58e49e4561ac9505936db7743a) for Objective 2, as indicated in lines 407 and 408 of the attached manuscript. Development of R shiny dashboard for Objective 3

We developed R shiny dashboard and uploaded the app into R shiny server at http://167.71.249.72:3838/AMR-Dashboard/.  This app gives same results as was produced by Esri’s dashboard.  Figures 3A and 3B in the attached manuscript explain how the dashboard operates, see lines 249 to 283.  The dashboard provides an interactive visualization of antibiotic resistance data using the R Shiny framework. Users are welcomed with a message guiding them to select a species from a dropdown menu (default: Staphylococcus aureus) and download data as a CSV file. The dashboard includes various visualizations such as a Source Distribution plot, a Geographical Distribution map for Kampala, a Samples by Year bar chart (2019-2022), a Gender Distribution pie chart, and Antibiotic Resistance plots for antibiotics like Amikacin and Ampicillin. When " Klebsiella aerogenes" is selected, the dashboard updates dynamically to display visualizations specific to this species. Source distribution shows sample locations, with geographical data pinpointing cases in Lugala (Figure 3B). The Samples by Year plot indicates an increase in sample counts over time, and the Antibiotic Resistance charts reveal resistance patterns, such as full resistance to Ampicillin and susceptibility to Amikacin. Data can be exported in CSV format using the "Download Results" button. The “app.R” Shiny application is attached, and you can also find it on GitHub (refer to line 348 of the attached manuscript). The simulated dataset, “Kampala_data.csv,” which is used to create the dashboard, is attached as well. It is also available on GitHub within the `data` folder (see lines 267-286 and line 412 of the attached manuscript). Additionally, instructions for installing and using the app are attached and can be found on GitHub (refer to lines 414 and 416 of the manuscript).

There are a few minor comments about the way it is written:

Reviewer:

  • Methods in Abstract: please rewrite the section to avoid the terms "Objective 1" etc: those terms read like a grant application or project plan and don't really fit the report of a published article.

    Response to the Reviewer

  • We have rewritten the Methods in the abstract as suggested. See lines 30 to 35 in the attached manuscript.

  Reviewer:

  • Introduction first paragraph: authors refer to both UTIs and poultry systems - which is fine (if a bit abrupt). It would be helpful if the authors were to introduce the One Health framing first, because then the link between the human and agricultural aspects would be more logical.(I note that One Health is referred to in the next paragraph - what is needed is a short description of the idea in paragraph 1, with citation, and perhaps justification as to why it is especially important in sub-Saharan Africa (and lower income countries more generally  - as implied by the reference to Nepal))

Response to the Reviewer:

  • We have introduced one-health and referenced it the manuscript.  See lines 80 to 82 in the manuscript, and the reference in line 360.

Reviewer:

  • Introduction - penaultimate paragraph reads a bit strange - I would suggest deleting that - it is OK to reference the project abstract - but really what we are looking for is a description of the research, not the details of the Vivli data challenge.

Response to the Reviewer:

  • We have deleted the section and added the information on the abstract to lines 113 and 114 of the attached manuscript.

Reviewer:

  • In Objective 3, the phrase "Specifically, let’s focus" is too colloquial and needs modifying.

Response to the Reviewer:

We have modified the phrase.  See lines 174 to 176 in the attached manuscript.

Wellcome Open Res. 2024 May 16. doi: 10.21956/wellcomeopenres.23245.r82552

Reviewer response for version 1

MdAbdus Salam 1

The article entitled ‘ Empowering Global AMR Research Community: Interactive GIS dashboards for AMR data analysis and informed decision-making’ is an original, innovative, and evidence-based work. To my opinion, it is a very good work that bridges the information gap and strategies to address global AMR issue in general and Uganda in particular. The research objectives have been achieved and reflected in the results.  Sufficient details of methods and analysis are provided to allow replication by others.  Data sources underlying the results are available and methodologies used are reproducible. As a whole there is no issue with language but there are some typos and minor suggestions as appended below.

Under ‘Plain language summary’

I suggest ‘visualize and analyze data’, instead of analyze and visualize in the.

Under ‘Abstract’

I suggest to add ‘AMR’ before the word data in the 2 nd line of ‘Methods’.

Under ‘Introduction’

A sustained increase in resistance among commonly used antibiotics in surgical wards of a Ugandan hospital from 2014 to 2018 underscores the need for ongoing monitoring, surveillance, and infection prevention and control practices.

The above sentence should be included under the first paragraph of ‘Introduction’.

However, accessing this data necessitated the submission of a 300-word abstract. The team submitted an abstract

I suggest to replace ‘this’ with ‘these’.

Under ‘Results’ (2 nd paragraph)

healthcare professionals to analyze and explore data

I suggest to change as to explore and analyze for the above sentence.

The limitation(s) has not been mentioned in the ‘Conclusion’, so I checked ‘partly’ for question #6.

I would like advice to address the typos and  to accommodate other suggestions for better clarity of the article.

Is the work clearly and accurately presented and does it cite the current literature?

Yes

If applicable, is the statistical analysis and its interpretation appropriate?

Yes

Are all the source data underlying the results available to ensure full reproducibility?

Yes

Is the study design appropriate and is the work technically sound?

Yes

Are the conclusions drawn adequately supported by the results?

Partly

Are sufficient details of methods and analysis provided to allow replication by others?

Yes

Reviewer Expertise:

NA

I confirm that I have read this submission and believe that I have an appropriate level of expertise to confirm that it is of an acceptable scientific standard, however I have significant reservations, as outlined above.

Wellcome Open Res. 2024 Aug 25.
Stephen Opiyo 1

Dear Dr. Abdus Salam,

Thank you very much for taking the time to review our manuscript. We sincerely appreciate your valuable feedback. We will respond to each of your comments thoroughly. For clarity, your comments will be highlighted in red, while our responses will be indicated in blue. Kind regards, 

Stephen Response to Md.Abdus Salam, International Islamic University Malaysia,, Kuantan, Malaysia The article entitled ‘ Empowering Global AMR Research Community: Interactive GIS dashboards for AMR data analysis and informed decision-making’ is an original, innovative, and evidence-based work. To my opinion, it is a very good work that bridges the information gap and strategies to address global AMR issue in general and Uganda in particular. The research objectives have been achieved and reflected in the results.  Sufficient details of methods and analysis are provided to allow replication by others.  Data sources underlying the results are available and methodologies used are reproducible. As a whole there is no issue with language but there are some typos and minor suggestions as appended below.

Reviewer:

Under ‘Plain language summary’

I suggest ‘visualize and analyze data’, instead of analyze and visualize in the.

Response to the Reviewer:

We have change to ‘visualize and analyze data’. See line 54 of the attached manuscript. Reviewer:

Under ‘Abstract’

I suggest to add ‘AMR’ before the word data in the 2 nd line of ‘Methods’.

Response to the Reviewer:

We have added ‘AMR’ before the word data.  See line 30 of the attached manuscript. Reviewer:

Under ‘Introduction’

A sustained increase in resistance among commonly used antibiotics in surgical wards of a Ugandan hospital from 2014 to 2018 underscores the need for ongoing monitoring, surveillance, and infection prevention and control practices.

The above sentence should be included under the first paragraph of ‘Introduction’.

Response to the Reviewer:

We have moved “A sustained increase in resistance among commonly used antibiotics in surgical wards of a Ugandan hospital from 2014 to 2018 underscores the need for ongoing monitoring, surveillance, and infection prevention and control practices.” to the first paragraph.  See lines 81 to 83 in the attached manuscript.

Reviewer:

However, accessing this data necessitated the submission of a 300-word abstract. The team submitted an abstract

I suggest to replace ‘this’ with ‘these’.

Response to the Reviewer:

We have replaced ‘this’ with ‘these’. See line 100 of the attached manuscript.

Reviewer:

Under ‘Results’ (2 nd paragraph)

healthcare professionals to analyze and explore data

I suggest to change as to explore and analyze for the above sentence.

Response to the Reviewer:

We have change to ‘explore and analyze ‘. See line 180 of the attached manuscript.

Reviewer

The limitation(s) has not been mentioned in the ‘Conclusion’, so I checked ‘partly’ for question #6.

Response to the Reviewer:

We have added the paragraph below about the limitations of the study to the Conclusion. See lines 236 to 242 of the attached manuscript.

Limitations:

“However, the research confronts notable challenges, particularly the scarcity of comprehensive AMR data in Africa. Limited sample sizes, such as those in Uganda and Kenya, may not accurately reflect the full spectrum of resistance patterns. Furthermore, inconsistent data collection and reporting across Africa reduce the reliability and generalizability of dashboards, particularly for Uganda and Kenya. The study underscores the necessity for standardized data collection, enhanced laboratory capabilities, and increased investment in healthcare infrastructure to fully leverage dashboards in the fight against AMR in Africa”.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Data Availability Statement

    The ATLAS dataset cannot be made available as it is under license by a third party. However, the dataset can be requested from Vivli 44 using the following information:- Data contributor name: Pfizer (AMR); DOI: https://doi.org/10.25934/PR00007930; AMR ID: VIV00007930; and Dataset ID: ATLAS_Antibiotics

    The dataset for Objective 1, Supplementary_Table_2.xlsx is available for download at GitHub in the following 30 , similarly, dataset for Objective 2, Supplementary_Table_3.xlsx.zip 31 , is available at GitHub at 30, and dataset for Objective 3, Supplementary_Table_4.xlsx, is available at GitHub 32 . This publication is based on research using data from Pfizer, obtained through 44 .

    The dashboard creation codes for Objectives 1 and 2 are not available, as the dashboards were originally constructed using the graphical user interface (GUI) on ArcGIS. To replicate the dashboards, we can leverage open-source QGIS GIS software ( https://qgis.org/en/site/), utilizing the information outlined in the materials and methods section. The R Shiny app call “app.R” for creating dashboard for Objective 3 is available at GitHub in 45, and information about the Shiny app and instructions for installing the app is available in RMarkdown format, pdf format, and html format at GitHub in 46.


    Articles from Wellcome Open Research are provided here courtesy of The Wellcome Trust

    RESOURCES